<!DOCTYPE HTML>
<html lang="en">
<head>
<link rel="icon" href="icon/riboflavin.jpg">
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<link rel="stylesheet" href="../styles.css">
	<script src="https://ajax.googleapis.com/ajax/libs/jquery/3.4.1/jquery.min.js"></script>
	<script src="../functions.txt"> </script>
	<script id="MathJax-script" async
src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
<meta name="keywords" content="Nutrition, Assessment, riboflavin, deficiency, food intake, PDF">
<meta name="description" content="Free Web guide to the Nutritional Assessment of Riboflavin status at the individual, community and national level">
<meta name="author" content="Pentieva K">
<meta name="viewport" content="width=device-width, initial-scale=0.6">
	<title>Nutritional Assessment:  Riboflavin</title>
</head>
<body id="chapter">

<div id="content">
<div class="header">
	<a href="https://nutritionalassessment.org/"><img src="../figures/bookcover.jpg" alt="Book" width="150"
		height="200" class="cover"></a>
	<h1>Pentieva K,  Principles<br> of Nutritional Assessment:<br>Riboflavin
	</h1>
<p> 3rd Edition,  &nbsp;&nbsp;&nbsp;August 2024 </p>
<br>

<div class="abstract">
<p style="font-size:26px; text-align:center"><strong>Abstract</strong></p>
Ribo&shy;flavin is a component of flavin mononucleotide
(FMN) and flavin adenine dinucleotide (FAD) which
act as coenzymes of different flavo&shy;proteins involved
in oxidation-reduction reactions that are central to
energy production, intermediary metab&shy;olism, drug
metab&shy;olism and the maintenance of anti&shy;oxidant status.
Ribo&shy;flavin coenzymes are also required for the
metab&shy;olism of folate, vitamin&nbsp;B<sub>12</sub>, vitamin&nbsp;B<sub>6</sub>, and niacin
as well as for mobilization of iron from intracellular
stores. Classical signs of ribo&shy;flavin deficiency
(aribo&shy;flavinosis) generally occur in association with
other nutrient deficiencies, notably vitamin&nbsp;B<sub>6</sub>.
Ribo&shy;flavin deficiency has been described
predominantly in undernourished populations in low
income countries, but accumulating evidence
has shown that a suboptimal ribo&shy;flavin status is more
common than previously recognized among
populations in developed countries. Measurement of
the activity of glutathione reductase, with and without
the prosthetic group FAD, is the best method for
assessing tissue ribo&shy;flavin status, particularly in cases
of impaired ribo&shy;flavin status. The test measures tissue
saturation and long-term ribo&shy;flavin status, although
some confounding factors may influence its
performance. Urinary ribo&shy;flavin excretion levels in
casual or 24h urine specimens reflect dietary intake
but vary widely because concen&shy;trations are affected
by many non-nutritional factors. Concen&shy;trations of
ribo&shy;flavin, FMN and FAD in plasma or erythrocytesG
as well as measurement of the activity of
pyri&shy;dox&shy;amine phosphate oxidase and its activity
coefficient appear promising options for assessment
of ribo&shy;flavin status and warrant further exploration.
<span class="citeAs">
CITE AS:
Pentieva K,  Principles of Nutritional Assessment:  Ribo&shy;flavin  <cite> <a
href="https://nutritionalassessment.org/riboflavin/">https://nutritionalassessment.org/ riboflavin/</a
></cite><br>
Email:   k.pentieva@ulster.ac.uk
<br>Licensed under <a href="https://creativecommons.org/licenses/by/4.0/"><b>CC-BY-4.0</b></a>
<br><span data-tippy-content="Use the print option on your web browser (such as Firefox or Chrome), selecting as the
destination 'save as PDF', to save a PDF copy of the whole or just a range of pages of 
this chapter to your disk or cell-phone">
(<a href=""
target="right" > PDF </a>)
</span>
</span>
</div>
</div>
<div id="toc">
</div>



<h2 id="20b.1">20b.1  Riboflavin</h2>

Riboflavin (7,8-dimethyl-10-ribityl-isoalloxazine) was
first synthesized in 1935. Its structure consists of an
isoalloxazine ring attached to a ribityl side chain
<a href="#figure20b.1">Figure&nbsp;20b.1</a>. A&nbsp;detailed review of ribo&shy;flavin and
health is provided elsewhere

<span data-tippy-content="Powers H. J. (2003). Riboflavin (vitamin B-2) and health.
The American journal of clinical nutrition, 77(6), 1352–1360.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12791609/"
target="right" >Powers, 2003</a>;  </span>

<span data-tippy-content="Thakur, K., Tomar, S. K., Singh, A. K., Mandal, S., & Arora, S. (2017).
 Riboflavin and health: A&nbsp;review of recent human research. Critical reviews in food science and nutrition,
 57(17), 3650–3660.">
<a href="https://pubmed.ncbi.nlm.nih.gov/27029320/"
target="right" >Thakur et&nbsp;al., 2017</a>;  </span>

<span data-tippy-content="Suwannasom, N., Kao, I., Pruß, A., Georgieva, R., & Bäumler, H. (2020).
 Riboflavin: The Health Benefits of a Forgotten Natural Vitamin. International journal of molecular sciences,
 21(3), 950.">
<a href="https://pubmed.ncbi.nlm.nih.gov/32023913/"
target="right" >Suwannasom et&nbsp;al., 2020</a>).</span>


<h3 id="20b.1.1">20b.1.1  Functions of ribo&shy;flavin</h3>

Ribo&shy;flavin is a component of flavin mononucleotide
(FMN) and flavin adenine dinucleotide (FAD) which
act as coenzymes of different flavo&shy;proteins involved
in oxidation-reduction reactions that are central to
energy production, intermediary metab&shy;olism, drug
metab&shy;olism as well as the maintenance of anti&shy;oxidant
status
(<a href="#figure20b.1">Figure&nbsp;20b.1</a>).
<a id="figure20b.1"></a>	
<figure style="width: 50%">
<img src="figures/fig20b.1.jpg" class="hundred" alt="Figure20b.1">
<figcaption class="cap">	
Figure 20b.1: Structure of riboflavin and the two coenzymes
derived from flavin, flavin mononucleotide, and flavin adenine dinucleotide.
</figcaption>
</figure>
 Of the two coenzymes, FMN is
formed first, from free ribo&shy;flavin, by ATP-dependent
phos&shy;phoryla&shy;tion; a reaction catalyzed by cytosolic
flavo&shy;kinase (EC&nbsp;2.7.1.26). Next, most of this FMN is
combined with a molecule of ATP to form FAD; this
step is catalyzed by the FAD-dependent FAD
syn&shy;thetase (EC&nbsp;2.7.7.2). In turn, FAD can be
converted into forms covalently bound to tissue
proteins. Thyroid hormones regulate the synthesis of
FMN and FAD as well as the formation of the
covalently bound flavins



<span data-tippy-content="Rivlin R. S. (1970). Riboflavin metab&shy;olism. The New England journal of medicine, 283(9), 463–472.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/4915004/"
target="right" >Rivlin, 1970</a>; </span>

<span data-tippy-content="Pinto, J., & Rivlin, R. S. (1979). Regulation of formation of covalently bound flavins in liver and cerebrum by thyroid hormones. Archives of biochemistry and bio&shy;physics, 194(2), 313–320.">
<a href="https://pubmed.ncbi.nlm.nih.gov/443808/"
target="right" >Pinto and Rivlin, 1979</a>).</span>


<p>
Both FMN and FAD are also cofactors for several
enzymes, including glutathione reductase, xanthine oxidase, L&#8209;amino
oxidase, and nico&shy;tinamide adenine dinucleo&shy;tide
(NAD) dehy&shy;drogenase.   Results from animal studies
also suggest that flavins are cofactors in the cyclical
&beta;&#8209;oxi&shy;dation of fatty acids
<!--Not in Refs BRIT J. NUTR-->
<span data-tippy-content="Olpin, S. E., & Bates, C. J. (1982a). Lipid metab&shy;olism in riboflavin-deficient rats. 1. Effect of dietary lipids on riboflavin status and fatty acid profiles. The British journal of nutrition, 47(3), 577–596. ">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7082626/"
target="right" >Olpin and Bates, 1982a</a></span>;

<span data-tippy-content="Olpin, S. E., & Bates, C. J. (1982b). Lipid metab&shy;olism in riboflavin-deficient rats. 2. Mitochondrial fatty acid oxidation and the microsomal desaturation pathway. The British journal of nutrition, 47(3), 589–596. ">
<a href="https://pubmed.ncbi.nlm.nih.gov/7082627/"
target="right" >Olpin and Bates, 1982b</a></span>).

Around 84% of human flavo&shy;proteins are
FAD&#8209;depen&shy;dent and only 16% use FMN as a cofactor


<span data-tippy-content="Lienhart, W. D., Gudipati, V., & Macheroux, P. (2013). The human flavo&shy;proteome. Archives of bio&shy;chemistry and bio&shy;physics, 535(2), 150–162.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/23500531/"
target="right" >Leinhart et&nbsp;al., 2013</a>). </span>

<p>
Ribo&shy;flavin coenzymes are also involved in the
metab&shy;olism of four other
vitamins — folate, vitamin&nbsp;B<sub>12</sub>, vitamin&nbsp;B<sub>6</sub>, and niacin. Flavin adenine
dinucleo&shy;tide is a cofactor for 5,10&#8209;methyl&shy;enetetra&shy;hydro&shy;folate
reductase (MTHFR; EC&nbsp;1.7.99.5), a key enzyme in folate metab&shy;olism involved
in the conversion of 5,10&#8209;methyl&shy;enetetra&shy;hydro&shy;folate
to 5-methyl&shy;tetra&shy;hydro&shy;folate, which is required for the
remethylation of homo&shy;cysteine to meth&shy;ionine. Both
<!--error fixed here-->
FMN and FAD act as cofactors for the enzyme
meth&shy;ionine synthase reductase (EC&nbsp;1.16.1.8) which is
responsible for the regeneration of methyl&shy;cobalamin,
the bio&shy;logically active form of vitamin&nbsp;B<sub>12</sub> that is
also involved in the remethyl&shy;ation of homo&shy;cysteine to
meth&shy;ionine. In addition, FMN acts as a cofactor for
pyri&shy;dox&shy;ine (pyridox&shy;amine) phos&shy;phate oxidase (PPO;
EC&nbsp;1.4.3.5), an important enzyme in vitamin&nbsp;B<sub>6</sub>
metab&shy;olism that converts the 5&#8209;phos&shy;phates of both
pyri&shy;dox&shy;ine and pyri&shy;dox&shy;amine to the coenzyme
pyri&shy;dox&shy;al&#8209;5´&#8209;phos&shy;phate.
Finally, the FAD&#8209;dependent kynurenine hydroxylase is involved in
the conversion of tryptophan to niacin.
As a result, severe ribo&shy;flavin
deficiency can cause functional deficiency with
disturb&shy;ances in the meta&shy;bolic pathways of these
vitamins.
<p>
Absorption of ribo&shy;flavin occurs mainly in the
proximal small intestine by a saturable
carrier-mediated mechanism; the maximal amount of
ribo&shy;flavin that can be absorbed from a single dose is
about 27mg

<span data-tippy-content="Zempleni, J., Galloway, J. R., & McCormick, D. B. (1996). Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. The American journal of clinical nutrition, 63(1), 54–66.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/8604671/"
target="right" >Zempleni et&nbsp;al., 1996</a>). </span>

Intestinal micro&shy;flora is able to synthesize ribo&shy;flavin,
some of which is absorbed in the colon by a
carrier-mediated process


<span data-tippy-content="Said, H. M., Ortiz, A., Moyer, M. P., & Yanagawa, N. (2000). Riboflavin uptake by human-derived colonic epithelial NCM460 cells. American journal of physiology. Cell physiology, 278(2), C270–C276.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/10666022/"
target="right" >Said et&nbsp;al., 2000</a>;  </span>

<span data-tippy-content="Said H. M. (2013). Recent advances in transport of water-soluble vitamins in organs of the digestive system: a focus on the colon and the pancreas. American journal of physiology. Gastrointestinal and liver physiology, 305(9), G601–G610.">
<a href="https://pubmed.ncbi.nlm.nih.gov/23989008/"
target="right" >Said, 2013</a> ).</span>

The vitamin is transported in plasma as free
ribo&shy;flavin complexed with albumin and other proteins,
mainly immuno&shy;globulins, which also bind flavin
coenzymes

<span data-tippy-content="Innis, W. S., McCormick, D. B., & Merrill, A. H., Jr (1985). Variations in riboflavin binding by human plasma: identification of immuno&shy;globulins as the major proteins responsible. Biochemical medicine, 34(2), 151–165.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/4084240/"
target="right" >Innis et&nbsp;al., 1985</a></span>).

<h3 id="20b.1.2">20b.1.2   Deficiency of ribo&shy;flavin in humans</h3>

The classical signs of ribo&shy;flavin deficiency, termed
aribo&shy;flavinosis, are angular stomatitis, cheilosis,
glossitis and anemia. Corneal vascular&shy;ization,
dermato&shy;logical changes, and neuro&shy;logical alterations
may also occur but are not specific for aribo&shy;flavinosis

<span data-tippy-content="Northrop-Clewes, C. A., & Thurnham, D. I. (2012). The discovery and characterization of riboflavin. Annals of nutrition & metab&shy;olism, 61(3), 224–230.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/23183293/"
target="right" >Northrop-Clewes and Thurnham, 2012</a>). </span>

Some environ&shy;mental factors may also influence the clinical
signs and symptoms of ribo&shy;flavin deficiency.
<p>
Aribo&shy;flavinosis is rarely encountered in isolation,
usually occurring in association with other vitamin
deficiency states. In a study of Irish elderly, 49% had
suboptimal ribo&shy;flavin status, 39% had suboptimal
vitamin&nbsp;B<sub>6</sub> status, and 21% had con&shy;current ribo&shy;flavin
and vitamin&nbsp;B<sub>6</sub> deficiencies. After supple&shy;mentation
with ribo&shy;flavin alone, both the ribo&shy;flavin deficiency
and the low plasma pyri&shy;dox&shy;al&#8209;5´&#8209;phos&shy;phate levels
were corrected

<span data-tippy-content="Madigan, S. M., Tracey, F., McNulty, H., Eaton-Evans, J., Coulter, J., McCartney, H., & Strain, J. J. (1998). Riboflavin and vitamin B-6 intakes and status and bio&shy;chemical response to riboflavin supple&shy;mentation in free-living elderly people. The American journal of clinical nutrition, 68(2), 389–395.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/9701198/"
target="right" >Madigan et&nbsp;al., 1998</a>). </span>

<p>
Some evidence suggests that ribo&shy;flavin deficiency is
linked with impaired mobilization of iron from
intra&shy;cellular stores (i.e. hepatic ferritin), increased rate
of iron loss from the gastro&shy;intestinal tract, as well as
decreased absorption of iron

<span data-tippy-content="Powers H. J. (2003). Riboflavin (vitamin B-2) and health. The American journal of clinical nutrition, 77(6), 1352–1360.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12791609/"
target="right" >Powers, 2003</a>). </span>

This could explain the low hemoglobin con&shy;cen&shy;trations and
hypo&shy;chromic anemia which often are observed in
ribo&shy;flavin deficiency

<span data-tippy-content="Aljaadi, A. M., How, R. E., Loh, S. P., Hunt, S. E., Karakochuk, C. D., Barr, S. I., McAnena, L., Ward, M., McNulty, H., Khor, G. L., Devlin, A. M., & Green, T. J. (2019). Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age. The Journal of nutrition, 149(11), 1952–1959.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/31318024/"
target="right" >Aljaadi et&nbsp;al., 2019</a>). </span>

Studies conducted in population groups with a com&shy;promised
ribo&shy;flavin status such as school children

<span data-tippy-content="Buzina, R., Jusić, M., Milanović, N., Sapunar, J., & Brubacher, G. (1979). The effects of riboflavin administration on iron metab&shy;olism parameters in a school-going population. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 49(2), 136–143.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/468468/"
target="right" >Buzina et&nbsp;al., 1979</a>;  </span>

<span data-tippy-content="Charoenlarp, P., Pholpothi, T., Chatpunyaporn, P., & Schelp, F. P. (1980). The effect of riboflavin on the hemat&shy;ologic changes in iron supple&shy;mentation of schoolchildren. The Southeast Asian journal of tropical medicine and public health, 11(1), 97–103.">
<a href="https://pubmed.ncbi.nlm.nih.gov/6996113/"
target="right" >Charoenlarp et&nbsp;al., 1980</a>), </span>

men

<span data-tippy-content="Fairweather-Tait, S. J., Powers, H. J., Minski, M. J., Whitehead, J., & Downes, R. (1992). Riboflavin deficiency and iron absorption in adult Gambian men. Annals of nutrition & metab&shy;olism, 36(1), 34–40.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/1590670/"
target="right" >Fairweather-Tait et&nbsp;al., 1992</a>),  </span> pregnant

<span data-tippy-content="Decker, K., Dotis, B., Glatzle, D., & Hinselmann, M. (1977). Riboflavin status and anaemia in pregnant women. Nutrition and metab&shy;olism, 21 Suppl 1, 17–19.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/335281/"
target="right" >Decker et&nbsp;al., 1977</a>;  </span>

<span data-tippy-content="Suprapto, B., Widardo, & Suhanantyo (2002). Effect of low-dosage vitamin A and riboflavin on iron-folate supple&shy;mentation in anaemic pregnant women. Asia Pacific journal of clinical nutrition, 11(4), 263–267.">
<a href="https://pubmed.ncbi.nlm.nih.gov/12495257/"
target="right" >Suprapto et&nbsp;al., 2002</a>;   </span>

<span data-tippy-content="Ma, A. G., Schouten, E. G., Zhang, F. Z., Kok, F. J., Yang, F., Jiang, D. C., Sun, Y. Y., & Han, X. X. (2008). Retinol and riboflavin supple&shy;mentation decreases the prevalence of anemia in Chinese pregnant women taking iron and folic Acid supple&shy;ments. The Journal of nutrition, 138(10), 1946–1950.">
<a href="https://pubmed.ncbi.nlm.nih.gov/18806105/"
target="right" >Ma et&nbsp;al., 2008</a>)</span>,
lactating

<span data-tippy-content="Powers, H. J., Bates, C. J., & Lamb, W. H. (1985). Haematological response to supple&shy;ments of iron and riboflavin to pregnant and lactating women in rural Gambia. Human nutrition. Clinical nutrition, 39(2), 117–129.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/4019262/"
target="right" >Powers et&nbsp;al., 1985</a>)  </span>

and women of reproductive age

<span data-tippy-content="Powers, H. J., Hill, M. H., Mushtaq, S., Dainty, J. R., Majsak-Newman, G., & Williams, E. A. (2011). Correcting a marginal riboflavin deficiency improves hemat&shy;ologic status in young women in the United Kingdom (RIBOFEM). The American journal of clinical nutrition, 93(6), 1274–1284.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/21525198/"
target="right" >Powers et&nbsp;al., 2011</a>)</span>, have shown
that ribo&shy;flavin supple&shy;mentation leads to improve&shy;ment
of  the hemat&shy;ological status.
<p>
Ribo&shy;flavin deficiency has been described in
under&shy;nourished pop&shy;ulations in several low income
countries, notably among women and children in The Gambia

<span data-tippy-content="Bates, C. J., Prentice, A. M., Paul, A. A., Sutcliffe, B. A., Watkinson, M., & Whitehead, R. G. (1981). Riboflavin status in Gambian pregnant and lactating women and its implications for Recommended Dietary Allowances. The American journal of clinical nutrition, 34(5), 928–935.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7234718/"
target="right" >Bates et&nbsp;al., 1981</a>, </span>

<span data-tippy-content="Bates, C. J., Evans, P. H., Allison, G., Sonko, B. J., Hoare, S., Goodrich, S., & Aspray, T. (1994). Biochemical indices and neuromuscular function tests in rural Gambian schoolchildren given a riboflavin, or multivitamin plus iron, supple&shy;ment. The British journal of nutrition, 72(4), 601–610.">
<a href="https://pubmed.ncbi.nlm.nih.gov/7986790/"
target="right" >1994</a>)</span>

, some elderly persons in Guatemala

<span data-tippy-content="Boisvert, W. A., Castañeda, C., Mendoza, I., Langeloh, G., Solomons, N. W., Gershoff, S. N., & Russell, R. M. (1993). Prevalence of riboflavin deficiency among Guatemalan elderly people and its relationship to milk intake. The American journal of clinical nutrition, 58(1), 85–90.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/8317395/"
target="right" >Boisvert et&nbsp;al., 1993a</a>), </span>

children in C&ocirc;te d'Ivoire

<span data-tippy-content="Rohner, F., Zimmermann, M. B., Wegmueller, R., Tschannen, A. B., & Hurrell, R. F. (2007). Mild riboflavin deficiency is highly prevalent in school-age children but does not increase risk for anaemia in Côte d'Ivoire. The British journal of nutrition, 97(5), 970–976.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/17381972/"
target="right" >Rohner et&nbsp;al., 2007</a>), </span>

and in some adol&shy;escent refugees from Bhutan living in
south&shy;eastern Nepal

<span data-tippy-content="Blanck, H. M., Bowman, B. A., Serdula, M. K., Khan, L. K., Kohn, W., Woodruff, B. A., & Bhutanese Refugee Investigation Group (2002). Angular stomatitis and riboflavin status among adolescent Bhutanese refugees living in southeastern Nepal. The American journal of clinical nutrition, 76(2), 430–435.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12145018/"
target="right" >Blanck et&nbsp;al., 2002</a>). </span>

Infants of mothers with a low ribo&shy;flavin status during gestation
are also likely to be born ribo&shy;flavin-deficient

<span data-tippy-content="Bates, C. J., Prentice, A. M., Paul, A. A., Prentice, A., Sutcliffe, B. A., & Whitehead, R. G. (1982). Riboflavin status in infants born in rural Gambia, and the effect of a weaning food supple&shy;ment. Transactions of the Royal Society of Tropical Medicine and Hygiene, 76(2), 253–258.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7101408/"
target="right" >Bates et&nbsp;al., 1982</a>).  </span>

An accumulating body of evidence based
on small as well as pop&shy;ulation-based surveys from
developed countries has shown that a sub&shy;optimal
ribo&shy;flavin status is more common than previously
recognized and those pre&shy;domin&shy;antly affected are
adol&shy;escents and young women

<span data-tippy-content="Bates B, Cox L, Nicholson S, Page P, Prentice A, Steer T, Swan G. (2016). National Diet and Nutrition Survey Results from Years 5 and 6 (combined) of the Rolling Programme (2012/2013 – 2013/2014). A&nbsp;survey carried out on behalf of the Department of Health and the Food Standards Agency. [Accessed: January 2021 at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf ]">
(<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf"
target="right" >Bates et&nbsp;al., 2016</a>;  </span>

<span data-tippy-content="Ward, M., Hughes, C. F., Strain, J. J., Reilly, R., Cunningham, C., Molloy, A. M., Horigan, G., Casey, M., McCarroll, K., O'Kane, M., Gibney, M. J., Flynn, A., Walton, J., McNulty, B. A., McCann, A., Kirwan, L., Scott, J. M., & McNulty, H. (2020). Impact of the common MTHFR 677C→T poly&shy;morphism on blood pressure in adulthood and role of riboflavin in modifying the genetic risk of hypertension: evidence from the JINGO project. BMC medicine, 18(1), 318.">
<a href="https://pubmed.ncbi.nlm.nih.gov/33172445/"
target="right" >Ward et&nbsp;al., 2020</a>;  </span>

<span data-tippy-content="Aljaadi, A. M., How, R. E., Loh, S. P., Hunt, S. E., Karakochuk, C. D., Barr, S. I., McAnena, L., Ward, M., McNulty, H., Khor, G. L., Devlin, A. M., & Green, T. J. (2019). Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age. The Journal of nutrition, 149(11), 1952–1959.">
<a href="https://pubmed.ncbi.nlm.nih.gov/31318024/"
target="right" >Aljaadi et&nbsp;al., 2019</a>;  </span>

<span data-tippy-content="Jungert A, McNulty H, Hoey L, Ward M, Strain JJ, Hughes CF, McAnena L, Neuhäuser-Berthold M, Pentieva K. (2020). Riboflavin is an important determinant of vitamin B-6 status in healthy adult">
<a href="https://pubmed.ncbi.nlm.nih.gov/32805038/"
target="right" >Jungert et&nbsp;al., 2020</a>).  </span>
<p>
Several conditions, including alcoholism, diabetes
mellitus, liver disease, thyroid and adrenal
insufficiency, and gastro&shy;intestinal and biliary
obstruction, may precipitate or exacerbate ribo&shy;flavin
deficiency

<span data-tippy-content="Rivlin RS. (2007).
Riboflavin. In: Zempleni J, Rucker RB,
McCormick DB, Suttie JW (ed.) Handbook of
Vitamins, 4th edition. CRC Press, Boca Raton, pp. 233-252.   *** NOT ON MEDLINE ***">
(<a href=""
target="right" >Rivlin, 2007</a></span>).

Alcohol causes deficiency
by interfering with both the digestion and the
intestinal absorption of ribo&shy;flavin

S<span data-tippy-content="Pinto, J., Huang, Y. P., & Rivlin, R. S. (1987). Mechanisms underlying the differential effects of ethanol on the bio&shy;availability of riboflavin and flavin adenine dinucleotide. The Journal of clinical investigation, 79(5), 1343–1348.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/3033022/"
target="right" >Pinto et&nbsp;al., 1987</a>;  </span>

<span data-tippy-content="Subramanian, V. S., Subramanya, S. B., Ghosal, A., & Said, H. M. (2013). Chronic alcohol feeding inhibits physiological and molecular parameters of intestinal and renal riboflavin transport. American journal of physiology. Cell physiology, 305(5), C539–C546.">
<a href="https://pubmed.ncbi.nlm.nih.gov/23804199/"
target="right" >Subramanian et&nbsp;al., 2013</a>  </span>).

Anti&shy;epileptic and
psycho&shy;tropic drugs such as chlor&shy;promazine,
imipramine, and amitriptyline

<span data-tippy-content="Apeland, T., Mansoor, M. A., Pentieva, K., McNulty, H., & Strandjord, R. E. (2003). Fasting and post-methionine loading concen&shy;trations of homo&shy;cysteine, vitamin B2, and vitamin B6 in patients on antiepileptic drugs. Clinical chemistry, 49(6 Pt 1), 1005–1008.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12766014/"
target="right" >Apeland et&nbsp;al., 2003</a>;  </span>

<span data-tippy-content="Pinto, J., Huang, Y. P., Pelliccione, N., & Rivlin, R. S. (1982). Cardiac sensitivity to the inhibitory effects of chlorpromazine, imipramine and amitriptyline upon formation of flavins. Biochemical pharmacology, 31(21), 3495–3499.">
<a href="https://pubmed.ncbi.nlm.nih.gov/7150370/"
target="right" >Pinto et&nbsp;al., 1982)</a>,  </span>

as well as some anti&shy;malarial drugs
such as quinacrine

<span data-tippy-content="Dutta, P., Pinto, J., & Rivlin, R. (1985). Antimalarial effects of riboflavin deficiency. Lancet (London, England), 2(8463), 1040–1043.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/2865519/"
target="right" >Dutta et&nbsp;al., 1985</a>)  </span>

 all inhibit the
conversion of ribo&shy;flavin to its active coenzyme
derivatives. Drugs, such as tetra&shy;cycline, theo&shy;phylline,
and caffeine, as well as metals, such as zinc, copper,
and iron, may chelate or form complexes with
ribo&shy;flavin and, hence, affect its bio&shy;avail&shy;ability

<span data-tippy-content="Sauberlich H. E. (1985). Bioavailability of vitamins. Progress in food & nutrition science, 9(1-2), 1–33.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/3911266/"
target="right" >Sauberlich, 1985</a>).  </span>

<p>
More vulnerable to ribo&shy;flavin deficiency are
individuals with 677C&rarr;T poly&shy;morphism in the gene
encoding MTHFR enzyme because the variant enzyme
has an impaired activity as a result of reduced affinity
to the cofactor FAD

<span data-tippy-content="Yamada, K., Chen, Z., Rozen, R., & Matthews, R. G. (2001). Effects of common poly&shy;morphisms on the properties of recombinant human methylenetetrahydrofolate reductase. Proceedings of the National Academy of Sciences of the United States of America, 98(26), 14853–14858.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/11742092/"
target="right" >Yamada et&nbsp;al., 2001</a>);  </span>

this typically leads to elevated homo&shy;cysteine con&shy;cen&shy;trations

<span data-tippy-content="Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J., den Heijer, M., Kluijtmans, L. A., & van den Heuvel, L. P. (1995). A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature genetics, 10(1), 111–113.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7647779/"
target="right" >Frosst et&nbsp;al., 1995</a>).  </span>

Marked lowering of homo&shy;cysteine has been achieved in people with the
impaired variant (TT&nbsp;genotype) with a low&nbsp;dose of ribo&shy;flavin

<span data-tippy-content="McNulty, H., Dowey, l., Strain, J. J., Dunne, A., Ward, M., Molloy, A. M., McAnena, L. B., Hughes, J. P., Hannon-Fletcher, M., & Scott, J. M. (2006). Riboflavin lowers homo&shy;cysteine in individuals homozygous for the MTHFR 677C->T poly&shy;morphism. Circulation, 113(1), 74–80.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/16380544/"
target="right" >McNulty et&nbsp;al., 2006</a>).  </span>

Moreover, genome-wide association studies

<span data-tippy-content="International Consortium for Blood Pressure Genome-Wide Association Studies, Ehret, G. B., Munroe, P. B., Rice, K. M., Bochud, M., Johnson, A. D., Chasman, D. I., Smith, A. V., Tobin, M. D., Verwoert, G. C., Hwang, S. J., Pihur, V., Vollenweider, P., O'Reilly, P. F., Amin, N., Bragg-Gresham, J. L., Teumer, A., Glazer, N. L., Launer, L., Zhao, J. H., … Johnson, T. (2011). Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature, 478(7367), 103–109.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/21909115/"
target="right" >Ehret et&nbsp;al., 2011</a>)  </span>

and clinical studies

<span data-tippy-content="Qian, X., Lu, Z., Tan, M., Liu, H., & Lu, D. (2007). A meta-analysis of association between C677T poly&shy;morphism in the methylenetetrahydrofolate reductase gene and hypertension. European journal of human genetics : EJHG, 15(12), 1239–1245.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/17726486/"
target="right" >Qian et&nbsp;al., 2007</a>;  </span>

<span data-tippy-content="Yang, K. M., Jia, J., Mao, L. N., Men, C., Tang, K. T., Li, Y. Y., Ding, H. X., & Zhan, Y. Y. (2014). Methylenetetrahydrofolate reductase C677T gene poly&shy;morphism and essential hypertension: A meta-analysis of 10,415 subjects. Biomedical reports, 2(5), 699–708.">
<a href="https://pubmed.ncbi.nlm.nih.gov/25054014/"
target="right" >Yang et&nbsp;al., 2014</a>)  </span>

provide evidence linking the MTHFR 677C&rarr;T
poly&shy;morphism with blood pressure and increased risk
of hyper&shy;tension and hyper&shy;tension in pregnancy by up
to 87%. Importantly, emerging evidence from
random&shy;ized trials highlights that ribo&shy;flavin
supple&shy;mentation can lower blood pressure specifically
in adults with TT&nbsp;genotype

<span data-tippy-content="Horigan, G., McNulty, H., Ward, M., Strain, J. J., Purvis, J., & Scott, J. M. (2010). Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C-->T poly&shy;morphism in MTHFR. Journal of hypertension, 28(3), 478–486.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/19952781/"
target="right" >Horigan et&nbsp;al., 2010</a>;  </span>

<span data-tippy-content="Wilson, C. P., McNulty, H., Ward, M., Strain, J. J., Trouton, T. G., Hoeft, B. A., Weber, P., Roos, F. F., Horigan, G., McAnena, L., & Scott, J. M. (2013). Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension (Dallas, Tex. : 1979), 61(6), 1302–1308.">
<a href="https://pubmed.ncbi.nlm.nih.gov/23608654/"
target="right" >Wilson et&nbsp;al., 2013</a>).  </span>

This novel role of ribo&shy;flavin
could have important public health implications,
considering that the frequency of the variant TT
genotype is 10&ndash;12% worldwide but it could reach up
to 32% in some countries (e.g., Mexico;

<span data-tippy-content="Wilcken, B., Bamforth, F., Li, Z., Zhu, H., Ritvanen, A., Renlund, M., Stoll, C., Alembik, Y., Dott, B., Czeizel, A. E., Gelman-Kohan, Z., Scarano, G., Bianca, S., Ettore, G., Tenconi, R., Bellato, S., Scala, I., Mutchinick, O. M., López, M. A., de Walle, H., … Botto, L. D. (2003). Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide. Journal of medical genetics, 40(8), 619–625.">
<a href="https://pubmed.ncbi.nlm.nih.gov/12920077/"
target="right" >Wilcken et&nbsp;al., 2003</a></span>).
<p>
Ribo&shy;flavin deficiency has been implicated as a risk
factor for cancer in animal studies

<span data-tippy-content="Powers H. J. (2003). Riboflavin (vitamin B-2) and health. The American journal of clinical nutrition, 77(6), 1352–1360.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12791609/"
target="right" >Powers, 2003</a>),  </span>

but the epidemiological evidence based on several meta-analyses is less consistent

<span data-tippy-content="Yoon, Y. S., Jung, S., Zhang, X., Ogino, S., Giovannucci, E. L., & Cho, E. (2016). Vitamin B2 intake and colorectal cancer risk; results from the Nurses' Health Study and the Health Professionals Follow-Up Study cohort. International journal of cancer, 139(5), 996–1008.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/27081929/"
target="right" >Yoon et&nbsp;al., 2016</a>; </span>

<span data-tippy-content="Yu, L., Tan, Y., & Zhu, L. (2017). Dietary vitamin B2 intake and breast cancer risk: a systematic review and meta-analysis. Archives of gynecology and obstetrics, 295(3), 721–729.">
<a href="https://pubmed.ncbi.nlm.nih.gov/28035488/"
target="right" >Yu et&nbsp;al., 2017</a>;  </span>

<span data-tippy-content="Ben, S., Du, M., Ma, G., Qu, J., Zhu, L., Chu, H., Zhang, Z., Wu, Y., Gu, D., & Wang, M. (2019). Vitamin B2 intake reduces the risk for colorectal cancer: a dose-response analysis. European journal of nutrition, 58(4), 1591–1602.">
<a href="https://pubmed.ncbi.nlm.nih.gov/29744609/"
target="right" >Ben et&nbsp;al., 2019</a>;  </span>

<span data-tippy-content="Zeng, J., Gu, Y., Fu, H., Liu, C., Zou, Y., & Chang, H. (2020). Association Between One-carbon Metabolism-related Vitamins and Risk of Breast Cancer: A Systematic Review and Meta-analysis of Prospective Studies. Clinical breast cancer, 20(4), e469–e480.">
<a href="https://pubmed.ncbi.nlm.nih.gov/32241696/"
target="right" >Zeng et&nbsp;al., 2020</a>).  </span>
<p>
Studies have shown that in malaria endemic regions,
individuals with ribo&shy;flavin deficiency are relatively
resistant to this infection and have a lower level of
parasitemia, but the course of the disease may be
more severe than in people with adequate ribo&shy;flavin status

<span data-tippy-content="Das, B. S., Das, D. B., Satpathy, R. N., Patnaik, J. K., & Bose, T. K. (1988). Riboflavin deficiency and severity of malaria. European journal of clinical nutrition, 42(4), 277–283.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/3293996/"
target="right" >Das et&nbsp;al., 1988</a>).  </span>

<h3 id="20b.1.3">20b.1.3  Food sources and dietary intakes</h3>

Ribo&shy;flavin in foods is present predominantly in the
form of FAD and only small quantities are available
as FMN. Some flavins bound covalently
to protein are also found in certain foods but are largely
unavailable as nutritional sources of ribo&shy;flavin; only
limited amounts apparently undergo digestion and
absorption

<span data-tippy-content="Chia, C. P., Addison, R., & McCormick, D. B. (1978). Absorption, metab&shy;olism, and excretion of 8alpha-(amino acid) riboflavins in the rat. The Journal of nutrition, 108(3), 373–381.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/627912/"
target="right" >Chia et&nbsp;al., 1978</a>).  </span>
<p>
The major food sources of ribo&shy;flavin are
dairy products, especially milk, and meat and fish; most plants contain
only small amounts of ribo&shy;flavin. As a result,
individuals consuming mainly plant-based diets may
be at risk for ribo&shy;flavin deficiency. Ribo&shy;flavin
enrichment of flour is mandated in the US and some
other countries with the aim of restoring the losses of
the vitamin during milling and refining processes.
Most of the ready-to-eat breakfast cereals are fortified
with ribo&shy;flavin in developed countries. Although it
is heat-stable, losses of ribo&shy;flavin do occur if it is
exposed to the light and, as it is water soluble, by
leaching into the cooking water

<span data-tippy-content="Powers H. J. (2003). Riboflavin (vitamin B-2) and health. The American journal of clinical nutrition, 77(6), 1352–1360.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12791609/"
target="right" >Powers, 2003</a>).  </span>

Bioavailability of ribo&shy;flavin from food is reported to be around 95%

<span data-tippy-content="IOM (Institute of Medicine). (2000). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academy Press, Washington, DC.
">
(<a href="https://pubmed.ncbi.nlm.nih.gov/23193625/"
target="right" >IOM, 2000</a>)</span>.

There are limited data
on the relative bio&shy;availability of ribo&shy;flavin from
different food sources but a study using stable
isotopes and kinetic modeling did not find a
significant difference in ribo&shy;flavin absorption from
milk and spinach

<span data-tippy-content="Dainty, J. R., Bullock, N. R., Hart, D. J., Hewson, A. T., Turner, R., Finglas, P. M., & Powers, H. J. (2007). Quantification of the bio&shy;availability of riboflavin from foods by use of stable-isotope labels and kinetic modeling. The American journal of clinical nutrition, 85(6), 1557–1564.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/17556693/"
target="right" >Dainty et&nbsp;al., 2007</a>).  </span>

<p>
Nationally representative surveys from the US,
Australia, Ireland, and the UK showed that milk and
dairy products, meat and ready-to-eat breakfast
cereals are the main dietary contributors to ribo&shy;flavin
intake

<span data-tippy-content="IOM (Institute of Medicine). (2000). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academy Press, Washington, DC.
">
(<a href="https://pubmed.ncbi.nlm.nih.gov/23193625/"
target="right" >IOM, 2000</a>;  </span>

<span data-tippy-content="Australian Bureau of Statistics. (2014). Australian Health Survey: Nutrition First Results - Foods and Nutrients. [Accessed in March 2021 at: https://www.abs.gov.au/statistics/health/health-conditions-and-risks/australian-health-survey-nutrition-first-results-foods-and-nutrients/latest-release#data-download ].">
<a href="https://www.abs.gov.au/statistics/health/health-conditions-and-risks/australian-health-survey-nutrition-first-results-foods-and-nutrients/latest-release"
target="right" >Australian Bureau of Statistics, 2014</a>;  </span>

<span data-tippy-content="National Adult Nutrition Survey (NANS, 2008-2010). (2011). Summary Report. [Accessed in March 2021 at: www.iuna.net/surveyreports].">
<a href="https://www.iuna.net/surveyreports"
target="right" >National Adult Nutrition Survey, 2011</a>;  </span>

<span data-tippy-content="Bates B, Cox L, Nicholson S, Page P, Prentice A, Steer T, Swan G. (2016). National Diet and Nutrition Survey Results from Years 5 and 6 (combined) of the Rolling Programme (2012/2013 – 2013/2014). A survey carried out on behalf of the Department of Health and the Food Standards Agency. [Accessed: January 2021 at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf ]">
<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf"
target="right" >Bates et&nbsp;al., 2016</a>).  </span>

<h3 id="20b.1.4">20b.1.4  Effects of high intakes of ribo&shy;flavin</h3>

In humans, there is no evidence for ribo&shy;flavin toxicity
as a result of excessive intakes

<span data-tippy-content="EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), Turck, D., Bresson, J. L., Burlingame, B., Dean, T., Fairweather-Tait, S., Heinonen, M., Hirsch-Ernst, K. I., Mangelsdorf, I., McArdle, H. J., Naska, A., Nowicka, G., Pentieva, K., Sanz, Y., Siani, A., Sjödin, A., Stern, M., Tomé, D., Van Loveren, H., Vinceti, M., … Neuhäuser-Berthold, M. (2017). Dietary Reference Values for riboflavin. EFSA journal. European Food Safety Authority, 15(8), e04919.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/32625611/"
target="right" >EFSA, 2017</a>).  </span>

The absorption of orally administered ribo&shy;flavin from both
vitamin supple&shy;ments and from natural foodstuffs is
limited, and high intakes are rapidly excreted in the
urine. Even when 400mg/d of ribo&shy;flavin was given
orally with meals for at least 3&nbsp;months, no short-term
side effects were reported

<span data-tippy-content="Schoenen, J., Lenaerts, M., & Bastings, E. (1994). High-dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia : an international journal of headache, 14(5), 328–329.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7828189/"
target="right" >Schoenen et&nbsp;al., 1994</a>).  </span>

In view of the limited data on adverse effects from high
intakes of ribo&shy;flavin, no Tolerable Upper Intake Level
for ribo&shy;flavin was set by the U.S. Food and Nutrition Board

<span data-tippy-content="IOM (Institute of Medicine). (2000). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academy Press, Washington, DC.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/23193625/"
target="right" >IOM, 2000</a>).  </span>

<h2 id="20b.2">20b.2  Biomarkers of ribo&shy;flavin status</h2>

As the signs and symptoms of ribo&shy;flavin deficiency
are not very specific, diagnosis of a deficiency state is
difficult when based exclusively on clinical
assessment. Consequently, bio&shy;chemical tests are
essential for confirming clinical cases of ribo&shy;flavin
deficiency and for estab&shy;lishing sub&shy;clinical
deficiencies. Several tests are available, and these are
discussed in the following sections. A&nbsp;combination of
bio&shy;markers is generally preferred: erythrocyte
glutathione reductase activity and urinary ribo&shy;flavin
excretion are the most used.

<h3 id="20b.2.1">20b.2.1 Erythrocyte glutathione reductase activity</h3>

The measurement of the activity coefficient of
erythrocyte glutathione reductase (EGR) (EC&nbsp;1.6.4.1),
an erythrocyte enzyme that depends on a cofactor
derived from ribo&shy;flavin, is the preferred method for
assessing ribo&shy;flavin status. It provides a measure of
tissue saturation and long-term ribo&shy;flavin status.
<p>
Glutathione reductase is a nicotinamide adenine
dinucleotide phosphate (NADPH), a FAD-dependent
enzyme, and the major flavo&shy;protein in erythrocytes. It
catalyzes the oxidative cleavage of the disulfide bond
of oxidized glutathione (GSSG) to form reduced
glutathione (GSH):
<p>
    \[\small\mbox{GSSG &plus; NADPH &plus; H}^{&plus;}\mbox{&rarr; 2GSH &plus; NADP}^{&plus;}\]
	
	The activity of EGR is measured
spectrophotometrically by monitoring the oxidation of
NADPH to NADP<sup>&plus;</sup> at 340nm, with and without the
presence of added FAD coenzyme. As an alternative,
the production of GSH can be monitored
colorimetrically. The test involves the following steps:
<ol>
<li class="numbered">  The basal activity of EGR is measured. This
represents the endogenous enzyme activity and
depends on the amount of FAD coenzyme in
erythrocytes.
<li class="numbered">
The activity of EGR with excess FAD
coenzyme added <i>in vitro</i> is then deter&shy;mined.
This represents the maximum potential EGR
activity and is referred to as &ldquo;stimulated&rdquo; activity.
<li class="numbered">
The activity coefficient (EGR&nbsp;AC) is then
derived by the ratio of the &ldquo;stimulated&rdquo; over
the basal EGR activity which indicates the
degree of unsaturation of the enzyme with the
coenzyme:
<p>
      \[\small\mbox{EGR&nbsp;AC &equals;}\frac{\mbox{activity (with added FAD)}}{\mbox{ basal activity (without added FAD)}}\]
</ol>
The basal and stimulated EGR activities can be
expressed per gram of hemoglobin, per number of
erythrocytes, or in terms of the volume of erythrocytes
(in mL).
<p>
The degree of <i>in vitro</i> stimulation of EGR activity
depends on the FAD saturation of the apoenzyme,
which, in turn, depends on the availability of
ribo&shy;flavin. If the vitamin status is normal, then the
values of the basal and stimulated activity are similar,
and the EGR activity coefficient is very close to 1.0.
In persons with ribo&shy;flavin deficiency, the basal EGR
activity falls and the <i>in vitro</i> stimulation by FAD
rises; thus, higher values of EGR activity coefficient
are indicative of a lower ribo&shy;flavin status. The result
also can be presented as &ldquo;percentage of stimulation&rdquo;
(PS) which is calculated from the EGR&nbsp;AC as follows:

\[\small\mbox{PS &equals; (EGR&nbsp;AC &times; 100) &minus; 100}\]
<p></p>
Meta-analysis of human supple&shy;mentation trials
confirmed that the EGR&nbsp;AC is a useful, stable, and
sensitive measure of ribo&shy;flavin status, reflecting the
degree of tissue saturation ranging from severe
deficiency to normal status

<span data-tippy-content="Hoey, L., McNulty, H., & Strain, J. J. (2009). Studies of bio&shy;marker responses to intervention with riboflavin: a systematic review. The American journal of clinical nutrition, 89(6), 1960S–1980S.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/19403631/"
target="right" >Hoey et&nbsp;al., 2009</a>).  </span>

It is not very sensitive, however, for detecting changes of
ribo&shy;flavin status in replete individuals

<span data-tippy-content="Powers H. J. (1999). Current knowledge concerning optimum nutritional status of riboflavin, niacin and pyri&shy;dox&shy;ine. The Proceedings of the Nutrition Society, 58(2), 435–440.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/10466188/"
target="right" >Powers, 1999</a>).  </span>

In experimentally controlled human studies,
concomitant increases in EGR&nbsp;AC in response to
decreases in intakes of ribo&shy;flavin have been reported
(<a href="#figure20b.2">Figure&nbsp;20b.2</a>).
<a id="figure20b.2"></a>	
<figure style="width: 50%">
<img src="figures/fig20b.2.jpg" class="hundred" alt="Figure20b.2">
<figcaption class="cap">	
Figure&nbsp;20b.2:   Relationship during depletion / repletion of
riboflavin intake to urinary riboflavin excretion and
erythrocyte glutathione reductase activity (EGR) coefficients.
The depletion phase (wk 2&ndash;10) involved
riboflavin intakes of 0.07mg/d. Redrawn from Tillotson and Baker
<span data-tippy-content="Tillotson, J. A., & Baker, E. M. (1972). An enzymatic measurement of the riboflavin status in man. The American journal of clinical nutrition, 25(4), 425–431.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/4400882/"
target="right" >1972</a>).  </span>
</figcaption>
</figure>

Nevertheless, the increase in the EGR&nbsp;AC does not
continue indefinitely; ribo&shy;flavin intakes
below 0.5mg/day do not produce any further increases in EGR&nbsp;AC

<span data-tippy-content="Sterner, R. T., & Price, W. R. (1973). Restricted riboflavin: within-subject behavioral effects in humans. The American journal of clinical nutrition, 26(2), 150–160.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/4145019/"
target="right" >Sterner and Price, 1973</a>).  </span>

Consequently, the extent to which the EGR&nbsp;AC is elevated does not
necessarily indicate the degree of ribo&shy;flavin
deficiency. Hence, it is not surprising that consistent
correlations between EGR&nbsp;AC values and clinical
signs of ribo&shy;flavin deficiency have not always been observed

<span data-tippy-content="Bates, C. J., Prentice, A. M., Paul, A. A., Sutcliffe, B. A., Watkinson, M., & Whitehead, R. G. (1981). Riboflavin status in Gambian pregnant and lactating women and its implications for Recommended Dietary Allowances. The American journal of clinical nutrition, 34(5), 928–935.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7234718/"
target="right" >Bates et&nbsp;al., 1981</a>).  </span>
<p>
Measurement of EGR&nbsp;AC has been used to monitor
ribo&shy;flavin status only in a few population-based
studies such as the UK National Dietary and Nutrition
Surveys Rolling Programme which includes all age
and sex population groups

<span data-tippy-content="Bates B, Cox L, Nicholson S, Page P, Prentice A, Steer T, Swan G. (2016). National Diet and Nutrition Survey Results from Years 5 and 6 (combined) of the Rolling Programme (2012/2013 – 2013/2014). A survey carried out on behalf of the Department of Health and the Food Standards Agency. [Accessed: January 2021 at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf ]">
(<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf"
target="right" >Bates et&nbsp;al., 2016</a>),  </span>

Irish National Adult Nutrition Survey

<span data-tippy-content="Kehoe L, Walton J, Hopkins SM, McNulty BA, Nugent AP, McNulty H, Ward M, Flynn A. Intake, status and dietary sources of riboflavin in a representative sample of Irish adults aged 18–90 years. Proc Nutr Soc. 2018; 77(OCE3): E66 [Abstract]. doi:10.1017/S0029665118000708">
(<a href="https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/intake-status-and-dietary-sources-of-riboflavin-in-a-representative-sample-of-irish-adults-aged-1890-years/74121166587A79B9A9203987555DAFB8"
target="right" >Kehoe et&nbsp;al., 2018</a>)  </span>

and the older national surveys from Germany

<span data-tippy-content="Heseker H, Schneider R, Moch KJ, Kohlmeier M, Kübler W. (1992). Vitaminversorgung Erwachsener in der Bundesrepublik Deutschland. VERA Schriftenreihe Band IV Wissenschaftlicher Fachverlag Dr. Fleck, Niederkleen, Germany.  &bull;&bull;&bull;NO PUBMED ENTRY&bull;&bull;&bull; ">
(<a href="https://www.google.com" target="right" >Heseker et&nbsp;al., 1992</a></span>)

 and the Netherlands

<span data-tippy-content="Löwik, M. R., van den Berg, H., Kistemaker, C., Brants, H. A., & Brussaard, J. H. (1994). Interrelationships between riboflavin and vitamin&nbsp;B6 among elderly people (Dutch Nutrition Surveillance System). International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 64(3), 198–203.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7814235/"
target="right" >Löwik et&nbsp;al., 1994</a>).  </span>

However, the assay has been used more
frequently in cohort studies of UK older adults

<span data-tippy-content="Bailey, A. L., Maisey, S., Southon, S., Wright, A. J., Finglas, P. M., & Fulcher, R. A. (1997). Relationships between micronutrient intake and bio&shy;chemical indicators of nutrient adequacy in a &ldquo;free-living&rdquo; elderly UK population. The British journal of nutrition, 77(2), 225–242.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/9135369/"
target="right" >Bailey et&nbsp;al., 1997</a>),  </span>

Irish adults

<span data-tippy-content="Jungert, A., McNulty, H., Hoey, L., Ward, M., Strain, J. J., Hughes, C. F., McAnena, L., Neuhäuser-Berthold, M., & Pentieva, K. (2020). Riboflavin Is an Important Determinant of Vitamin&nbsp;B-6 Status in Healthy Adults. The Journal of nutrition, 150(10), 2699–2706.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/32805038/"
target="right" >Jungert et&nbsp;al., 2020</a>)  </span>

and older people

<span data-tippy-content="Madigan, S. M., Tracey, F., McNulty, H., Eaton-Evans, J., Coulter, J., McCartney, H., & Strain, J. J. (1998). Riboflavin and vitamin&nbsp;B-6 intakes and status and bio&shy;chemical response to riboflavin supple&shy;mentation in free-living elderly people. The American journal of clinical nutrition, 68(2), 389–395.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/9701198/"
target="right" >Madigan et&nbsp;al., 1998</a>;  </span>

<span data-tippy-content="Moore, K., Hughes, C. F., Hoey, L., Ward, M., Cunningham, C., Molloy, A. M., Strain, J. J., McCarroll, K., Casey, M. C., Tracey, F., Laird, E., O'Kane, M., & McNulty, H. (2019). B-vitamins in Relation to Depression in Older Adults Over 60 Years of Age: The Trinity Ulster Department of Agriculture (TUDA) Cohort Study. Journal of the American Medical Directors Association, 20(5), 551–557.e1.">
<a href="https://pubmed.ncbi.nlm.nih.gov/30692033/"
target="right" >Moore et&nbsp;al., 2019</a>),  </span>

Canadian women of reproductive age

<span data-tippy-content="Aljaadi, A. M., How, R. E., Loh, S. P., Hunt, S. E., Karakochuk, C. D., Barr, S. I., McAnena, L., Ward, M., McNulty, H., Khor, G. L., Devlin, A. M., & Green, T. J. (2019). Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age. The Journal of nutrition, 149(11), 1952–1959.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/31318024/"
target="right" >Aljaadi et&nbsp;al., 2019</a>)  </span>

and older adults

<span data-tippy-content="Whitfield, K. C., da Silva, L., Feldman, F., Singh, S., McCann, A., McAnena, L., Ward, M., McNulty, H., Barr, S. I., & Green, T. J. (2019). Adequate vitamin&nbsp;B12 and riboflavin status from menus alone in residential care facilities in the Lower Mainland, British Columbia. Applied physiology, nutrition, and metab&shy;olism = Physiologie appliquee, nutrition et metab&shy;olisme, 44(4), 414–419.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/30248270/"
target="right" >Whitfield et&nbsp;al., 2019</a>),  </span>

Spanish adults

<span data-tippy-content="Mataix, J., Aranda, P., Sánchez, C., Montellano, M. A., Planells, E., & Llopis, J. (2003). Assessment of thiamin (vitamin&nbsp;B1) and riboflavin (vitamin&nbsp;B2) status in an adult Mediterranean population. The British journal of nutrition, 90(3), 661–666.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/13129473/"
target="right" >Mataix et&nbsp;al., 2003</a>;  </span>

<span data-tippy-content="García-Minguillán, C. J., Fernandez-Ballart, J. D., Ceruelo, S., Ríos, L., Bueno, O., Berrocal-Zaragoza, M. I., Molloy, A. M., Ueland, P. M., Meyer, K., & Murphy, M. M. (2014). Riboflavin status modifies the effects of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) poly&shy;morphisms on homo&shy;cysteine. Genes & nutrition, 9(6), 435.">
<a href="https://pubmed.ncbi.nlm.nih.gov/25322900/"
target="right" >García-Minguillán et&nbsp;al., 2014</a>)  </span>

as well as French adults

<span data-tippy-content="Hercberg, S., Preziosi, P., Galan, P., Devanlay, M., Keller, H., Bourgeois, C., Potier de Courcy, G., & Cherouvrier, F. (1994). Vitamin status of a healthy French population: dietary intakes and bio&shy;chemical markers. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 64(3), 220–232.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7814238/"
target="right" >Hercberg et&nbsp;al., 1994</a>).  </span>

Ribo&shy;flavin status of different
population groups assessed by EGR&nbsp;AC has been
reported in studies conducted in developing countries
including some in Africa

<span data-tippy-content="Bates, C. J., Prentice, A. M., Paul, A. A., Sutcliffe, B. A., Watkinson, M., & Whitehead, R. G. (1981). Riboflavin status in Gambian pregnant and lactating women and its implications for Recommended Dietary Allowances. The American journal of clinical nutrition, 34(5), 928–935.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7234718/"
target="right" >Bates et&nbsp;al., 1981</a>;  </span>

<span data-tippy-content="Bates, C. J., Evans, P. H., Allison, G., Sonko, B. J., Hoare, S., Goodrich, S., & Aspray, T. (1994). Biochemical indices and neuromuscular function tests in rural Gambian schoolchildren given a riboflavin, or multivitamin plus iron, supple&shy;ment. The British journal of nutrition, 72(4), 601–610.">
<a href="https://pubmed.ncbi.nlm.nih.gov/7986790/"
target="right" >1994</a>;  </span>

<span data-tippy-content="Ajayi O. A. (1984). Biochemical ariboflavinosis among Nigerian rural school children. Human nutrition. Clinical nutrition, 38(5), 383–389.">
<a href="https://pubmed.ncbi.nlm.nih.gov/6511484/"
target="right" >Ajayi, 1984</a>;  </span>

<span data-tippy-content="Ajayi O. A. (1985). Incidence of bio&shy;chemical riboflavin deficiency in Nigerian pregnant women. Human nutrition. Clinical nutrition, 39(2), 149–153.">
<a href="https://pubmed.ncbi.nlm.nih.gov/4019264/"
target="right" >1985</a>;  </span>

<span data-tippy-content="Ajayi, O. A., & James, O. A. (1984). Effect of riboflavin supple&shy;mentation on riboflavin nutriture of a secondary school population in Nigeria. The American journal of clinical nutrition, 39(5), 787–791.">
<a href="https://pubmed.ncbi.nlm.nih.gov/6711480/"
target="right" >Ajayi and James, 1984</a>),  </span>

Central America

<span data-tippy-content="Boisvert, W. A., Castañeda, C., Mendoza, I., Langeloh, G., Solomons, N. W., Gershoff, S. N., & Russell, R. M. (1993). Prevalence of riboflavin deficiency among Guatemalan elderly people and its relationship to milk intake. The American journal of clinical nutrition, 58(1), 85–90.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/8317395/"
target="right" >Boisvert et&nbsp;al., 1993a</a>),  </span>

and Asia

<span data-tippy-content="Thurnham, D. I., Rathakette, P., Hambidge, K. M., Munoz, N., & Crespi, M. (1982). Riboflavin, vitamin&nbsp;A and zinc status in Chinese subjects in a high-risk area for oesophageal cancer in China. Human nutrition. Clinical nutrition, 36(5), 337–349.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7174357/"
target="right" >Thurnham et&nbsp;al., 1982</a>;  </span>

<span data-tippy-content="Blanck, H. M., Bowman, B. A., Serdula, M. K., Khan, L. K., Kohn, W., Woodruff, B. A., & Bhutanese Refugee Investigation Group (2002). Angular stomatitis and riboflavin status among adolescent Bhutanese refugees living in southeastern Nepal. The American journal of clinical nutrition, 76(2), 430–435.">
<a href="https://pubmed.ncbi.nlm.nih.gov/12145018/"
target="right" >Blanck et&nbsp;al., 2002</a>;  </span>

<span data-tippy-content="Whitfield, K. C., Karakochuk, C. D., Liu, Y., McCann, A., Talukder, A., Kroeun, H., Ward, M., McNulty, H., Lynd, L. D., Kitts, D. D., Li-Chan, E. C., McLean, J., & Green, T. J. (2015). Poor thiamin and riboflavin status is common among women of childbearing age in rural and urban Cambodia. The Journal of nutrition, 145(3), 628–633.">
<a href="https://pubmed.ncbi.nlm.nih.gov/25733481/"
target="right" >Whitfield et&nbsp;al., 2015</a>;  </span>

<span data-tippy-content="Aljaadi, A. M., How, R. E., Loh, S. P., Hunt, S. E., Karakochuk, C. D., Barr, S. I., McAnena, L., Ward, M., McNulty, H., Khor, G. L., Devlin, A. M., & Green, T. J. (2019). Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age. The Journal of nutrition, 149(11), 1952–1959.">
<a href="https://pubmed.ncbi.nlm.nih.gov/31318024/"
target="right" >Aljaadi et&nbsp;al., 2019</a>).  </span>
<p>
Comparison of the prevalence of deficient ribo&shy;flavin
status among these studies is often difficult because
the method of EGR&nbsp;AC assessment has not been
standardized and as shown in a systematic evaluation
of the existing methods, variations in the laboratory
protocols applied in various  studies could produce
significantly different results

<span data-tippy-content="Hill, M. H., Bradley, A., Mushtaq, S., Williams, E. A., & Powers, H. J. (2009). Effects of methodological variation on assessment of riboflavin status using the erythrocyte glutathione reductase activation coefficient assay. The British journal of nutrition, 102(2), 273–278.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/19102813/"
target="right" >Hill et&nbsp;al., 2009</a>).  </span>

Moreover, the cutoff values used to denote suboptimal
status and deficiency vary considerably from one
study to another. However, EGR&nbsp;AC results from
different populations generated by an identical protocol
in one laboratory and by using the same cutoff
showed very comparable data for the prevalence of
ribo&shy;flavin deficiency in Canadian and Irish older
adults
(26% vs 25.5%;

<span data-tippy-content="Whitfield, K. C., da Silva, L., Feldman, F., Singh, S., McCann, A., McAnena, L., Ward, M., McNulty, H., Barr, S. I., & Green, T. J. (2019). Adequate vitamin&nbsp;B12 and riboflavin status from menus alone in residential care facilities in the Lower Mainland, British Columbia. Applied physiology, nutrition, and metab&shy;olism = Physiologie appliquee, nutrition et metab&shy;olisme, 44(4), 414–419.">
<a href="https://pubmed.ncbi.nlm.nih.gov/30248270/"
target="right" >Whitfield et&nbsp;al., 2019</a>;  </span>

<span data-tippy-content="Jungert, A., McNulty, H., Hoey, L., Ward, M., Strain, J. J., Hughes, C. F., McAnena, L., Neuhäuser-Berthold, M., & Pentieva, K. (2020). Riboflavin Is an Important Determinant of Vitamin&nbsp;B-6 Status in Healthy Adults. The Journal of nutrition, 150(10), 2699–2706.">
<a href="https://pubmed.ncbi.nlm.nih.gov/32805038/"
target="right" >Jungert et&nbsp;al., 2020</a>)  </span>

and in Canadian women of reproductive age and younger Irish adults (40%&nbsp;vs&nbsp; 52%;

<span data-tippy-content="Aljaadi, A. M., How, R. E., Loh, S. P., Hunt, S. E., Karakochuk, C. D., Barr, S. I., McAnena, L., Ward, M., McNulty, H., Khor, G. L., Devlin, A. M., & Green, T. J. (2019). Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age. The Journal of nutrition, 149(11), 1952–1959.">
<a href="https://pubmed.ncbi.nlm.nih.gov/31318024/"
target="right" >Aljaadi et&nbsp;al., 2019</a>;  </span>

<span data-tippy-content="Jungert, A., McNulty, H., Hoey, L., Ward, M., Strain, J. J., Hughes, C. F., McAnena, L., Neuhäuser-Berthold, M., & Pentieva, K. (2020). Riboflavin Is an Important Determinant of Vitamin&nbsp;B-6 Status in Healthy Adults. The Journal of nutrition, 150(10), 2699–2706.">
<a href="https://pubmed.ncbi.nlm.nih.gov/32805038/"
target="right" >Jungert et&nbsp;al., 2020</a>)  </span>

whereas 80% and 71%
of the investigated Malaysian and Cambodian women
of reproductive age, respectively were reported to be
ribo&shy;flavin deficient

<span data-tippy-content="Aljaadi, A. M., How, R. E., Loh, S. P., Hunt, S. E., Karakochuk, C. D., Barr, S. I., McAnena, L., Ward, M., McNulty, H., Khor, G. L., Devlin, A. M., & Green, T. J. (2019). Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age. The Journal of nutrition, 149(11), 1952–1959.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/31318024/"
target="right" >Aljaadi et&nbsp;al., 2019</a>;  </span>

<span data-tippy-content="Whitfield, K. C., Karakochuk, C. D., Liu, Y., McCann, A., Talukder, A., Kroeun, H., Ward, M., McNulty, H., Lynd, L. D., Kitts, D. D., Li-Chan, E. C., McLean, J., & Green, T. J. (2015). Poor thiamin and riboflavin status is common among women of childbearing age in rural and urban Cambodia. The Journal of nutrition, 145(3), 628–633.">
<a href="https://pubmed.ncbi.nlm.nih.gov/25733481/"
target="right" >Whitfield et&nbsp;al., 2015</a>).  </span>


<p></p>
In some of these surveys, significant inverse
relationships between the EGR&nbsp;AC and ribo&shy;flavin
intakes have been observed

<span data-tippy-content="The National Diet & Nutrition
Survey: adults aged 19 to 64 years,   The Stationery Office, London.">
(<a href="https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiMttqQhNzwAhUXyjgGHdOPAXQQFjABegQIAxAD&url=http%3A%2F%2Fdoc.ukdataservice.ac.uk%2Fdoc%2F5140%2Fmrdoc%2Fpdf%2F5140userguide.pdf&usg=AOvVaw3coxNXRbCkkby2YvIHdGTG"
target="right" >Gregory et&nbsp;al., 1990</a>;  </span>

<span data-tippy-content="Hercberg, S., Preziosi, P., Galan, P., Devanlay, M., Keller, H., Bourgeois, C., Potier de Courcy, G., & Cherouvrier, F. (1994). Vitamin status of a healthy French population: dietary intakes and bio&shy;chemical markers. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 64(3), 220–232.">
<a href="https://pubmed.ncbi.nlm.nih.gov/7814238/"
target="right" >Hercberg et&nbsp;al., 1994</a>;  </span>

<span data-tippy-content="Bailey, A. L., Maisey, S., Southon, S., Wright, A. J., Finglas, P. M., & Fulcher, R. A. (1997). Relationships between micronutrient intake and bio&shy;chemical indicators of nutrient adequacy in a &ldquo;free-living&rdquo; elderly UK population. The British journal of nutrition, 77(2), 225–242.">
<a href="https://pubmed.ncbi.nlm.nih.gov/9135369/"
target="right" >Bailey et&nbsp;al., 1997</a>;  </span>

<span data-tippy-content="Bates, C. J., Prentice, A., Cole, T. J., van der Pols, J. C., Doyle, W., Finch, S., Smithers, G., & Clarke, P. C. (1999). Micronutrients: highlights and research challenges from the 1994-5 National Diet and Nutrition Survey of people aged 65 years and over. The British journal of nutrition, 82(1), 7–15.">
<a href="https://pubmed.ncbi.nlm.nih.gov/10655951/"
target="right" >Bates et&nbsp;al., 1999</a>;  </span>

<span data-tippy-content="Hoey, L., McNulty, H., Askin, N., Dunne, A., Ward, M., Pentieva, K., Strain, J., Molloy, A. M., Flynn, C. A., & Scott, J. M. (2007). Effect of a voluntary food fortification policy on folate, related B vitamin status, and homo&shy;cysteine in healthy adults. The American journal of clinical nutrition, 86(5), 1405–1413.">
<a href="https://pubmed.ncbi.nlm.nih.gov/17991653/"
target="right" >Hoey et&nbsp;al., 2007</a>);  </span>

results from the UK survey of British adults are given in
<a href="#table20b.1">Table&nbsp;20b.1</a>.
<a id="table20b.1"></a>

<table>
<caption class="cap">
Table&nbsp;20b.1: Correlation coefficients between the erythrocyte
glutathione reductase activity coefficient and
dietary riboflavin intakes for U.K. adults. Data from
<span data-tippy-content="The National Diet & Nutrition
Survey: adults aged 19 to 64 years.    The Stationery Office, London.">
<a href="https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiMttqQhNzwAhUXyjgGHdOPAXQQFjABegQIAxAD&url=http%3A%2F%2Fdoc.ukdataservice.ac.uk%2Fdoc%2F5140%2Fmrdoc%2Fpdf%2F5140userguide.pdf&usg=AOvVaw3coxNXRbCkkby2YvIHdGTG"
target="right" >Gregory et&nbsp;al., 1990</a></span>

.
</caption>
<thead style="font-size: 18px; background-color: lavender;">
<tr><th><th  colspan="2">Erythrocyte<br>glutathione reductase
 <br>activity coefficient </th>
 <tr><th>Dietary intake<th> Men<th>Women</th>
</thead>
<tbody style="font-size: 15px">
<tr><td>Total riboflavin<br>(incl. supple&shy;ments)<td> &minus;0.13
( p &lt;&nbsp;0.01)<td>&minus;0.24  ( p &lt;&nbsp;0.01)
<tr><td> Riboflavin from <br>food sources <td> &minus;0.23
 ( p &lt;&nbsp;0.01)<td>&minus;0.31 ( p &lt;&nbsp;0.01)
</tr>
</tbody>
</table>
In the UK study of Norwich elderly

<span data-tippy-content="Bailey, A. L., Maisey, S., Southon, S., Wright, A. J., Finglas, P. M., & Fulcher, R. A. (1997). Relationships between micronutrient intake and bio&shy;chemical indicators of nutrient adequacy in a &ldquo;free-living&rdquo; elderly UK population. The British journal of nutrition, 77(2), 225–242.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/9135369/"
target="right" >Bailey et&nbsp;al., 1997</a>),  </span>

initial EGR&nbsp;AC values for both males and females were
significantly correlated with those measured 2y later
(<a href="#table20b.2">Table&nbsp;20b.2</a>),

suggesting that EGR&nbsp;AC may be a
reliable measure of long-term bio&shy;chemical ribo&shy;flavin
status of individuals. This finding is consistent with
earlier studies

<span data-tippy-content="Rutishauser, I. H., Bates, C. J., Paul, A. A., Black, A. E., Mandal, A. R., & Patnaik, B. K. (1979). Long-term vitamin status and dietary intake of healthy elderly subjects. 1. Riboflavin. The British journal of nutrition, 42(1), 33–42.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/486392/"
target="right" >Rutishauser et&nbsp;al., 1979</a>).  </span>

<p>
There have been several attempts to establish a
relationship in humans between a specific
physiological function and EGR&nbsp;AC values, but the
results have been inconclusive. Some reports of
effects on work performance, neurovascular
coordination, and iron handling with EGR&nbsp;AC values
&ge;&nbsp;1.7 have been reported

<span data-tippy-content="Prasad PA, Bamji MS, Lakshmi AV, Satyanarayama K. (1990). Functional impact of riboflavin supple&shy;mentation in urban school children. Nutrition Research 10: 275–282. https://doi.org/10.1016/S0271-5317(05)80269-6">
(<a href="https://www.sciencedirect.com/science/article/abs/pii/S0271531705802696?via%3Dihub"
target="right" >Prasad et&nbsp;al., 1990</a>;  </span>

<span data-tippy-content="Fairweather-Tait, S. J., Powers, H. J., Minski, M. J., Whitehead, J., & Downes, R. (1992). Riboflavin deficiency and iron absorption in adult Gambian men. Annals of nutrition & metab&shy;olism, 36(1), 34–40.">
<a href="https://pubmed.ncbi.nlm.nih.gov/1590670/"
target="right" >Fairweather-Tait et&nbsp;al., 1992</a>;  </span>

<span data-tippy-content="Bates, C. J., Evans, P. H., Allison, G., Sonko, B. J., Hoare, S., Goodrich, S., & Aspray, T. (1994). Biochemical indices and neuromuscular function tests in rural Gambian schoolchildren given a riboflavin, or multivitamin plus iron, supple&shy;ment. The British journal of nutrition, 72(4), 601–610.">
<a href="https://pubmed.ncbi.nlm.nih.gov/7986790/"
target="right" >Bates et&nbsp;al., 1994</a>).  </span>

<a id="table20b.2"></a>
<table>
<caption class="cap">
Table&nbsp;20b.2:  The correlation of EGR activity coefficients
measured on 99 subjects initially and after
2y. Signif&shy;icant correlation does not imply agreement
between initial and follow-up mean values. Data from
Bailey et&nbsp;al., British Journal of Nutrition 77: 225&ndash;242,
1997.
</caption>
<thead style="font-size: 18px; background-color: lavender;">
<tr><th>Elderly subjects <th>n <th>r<th> Significance
</th>
</thead>
<tbody style="font-size: 15px">
<tr><td>Males <td>&nbsp;&nbsp;37&nbsp;&nbsp;<td> 0.411<td>&lt;&nbsp;0.02
<tr><td>Females <td>62 <td>0.359<td> &lt;&nbsp;0.01
</tr>
</tbody>
</table>


In some supple&shy;mentation studies of subjects with
subclinical ribo&shy;flavin deficiency, no improvement in
physical performance or endurance has been reported

<span data-tippy-content="Prasad PA, Bamji MS, Lakshmi AV, Satyanarayama K. (1990). Functional impact of riboflavin supple&shy;mentation in urban school children. Nutrition Research 10: 275–282. https://doi.org/10.1016/S0271-5317(05)80269-6">
(<a href="https://www.sciencedirect.com/science/article/abs/pii/S0271531705802696?via%3Dihub"
target="right" >Prasad et&nbsp;al., 1990</a>;  </span>

<span data-tippy-content="Winters, L. R., Yoon, J. S., Kalkwarf, H. J., Davies, J. C., Berkowitz, M. G., Haas, J., & Roe, D. A. (1992). Riboflavin requirements and exercise adaptation in older women. The American journal of clinical nutrition, 56(3), 526–532.">
<a href="https://pubmed.ncbi.nlm.nih.gov/1503064/"
target="right" >Winters et&nbsp;al., 1992</a>;  </span>

<span data-tippy-content="van der Beek, E. J., van Dokkum, W., Wedel, M., Schrijver, J., & van den Berg, H. (1994). Thiamin, riboflavin and
vitamin&nbsp;B6: impact of restricted intake on physical performance in man. Journal of the American College of Nutrition, 13(6), 629–640.">
<a href="https://pubmed.ncbi.nlm.nih.gov/7706598/"
target="right" >van der Beek et&nbsp;al., 1994</a>).  </span>

However, a supple&shy;mental ribo&shy;flavin dose of 4mg/day given for 8wks
appeared to have a beneficial effect on hemat&shy;ologic
status in UK&nbsp;young women with a low ribo&shy;flavin
status (EGR&nbsp;AC &gt;&nbsp;1.65) at baseline

<span data-tippy-content="Powers, H. J., Hill, M. H., Mushtaq, S., Dainty, J. R., Majsak-Newman, G., & Williams, E. A. (2011). Correcting a marginal riboflavin deficiency improves hemat&shy;ologic status in young women in the United Kingdom (RIBOFEM). The American journal of clinical nutrition, 93(6), 1274–1284.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/21525198/"
target="right" >Powers et&nbsp;al., 2011</a>).  </span>

Furthermore, there is evidence that a low dose
ribo&shy;flavin supple&shy;mentation can lower an elevated
blood pressure, specifically in adults who are
genetically predisposed to develop hypertension

<span data-tippy-content="Horigan, G., McNulty, H., Ward, M., Strain, J. J., Purvis, J., & Scott, J. M. (2010). Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C-->T poly&shy;morphism in MTHFR. Journal of hypertension, 28(3), 478–486.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/19952781/"
target="right" >Horigan et&nbsp;al., 2010</a>;  </span>

<span data-tippy-content="Wilson, C. P., McNulty, H., Ward, M., Strain, J. J., Trouton, T. G., Hoeft, B. A., Weber, P., Roos, F. F., Horigan, G., McAnena, L., & Scott, J. M. (2013). Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension (Dallas, Tex. : 1979), 61(6), 1302–1308.">
<a href="https://pubmed.ncbi.nlm.nih.gov/23608654/"
target="right" >Wilson et&nbsp;al., 2013</a>; </span>see
<a href="#20b.1.2">Section&nbsp;20b.1.2</a>
on deficiency of ribo&shy;flavin in humans).
<p>
Some epidemiological studies also have linked EGR&nbsp;AC
values with various health effects. In a study of
adolescent Bhutanese refugees living in Nepal, for
example, in whom the prevalence of angular
stomatitis was 27%, those with angular stomatitis had
significantly higher EGR&nbsp;AC values than those
without (i.e., 2.2&nbsp;&pm;&nbsp;0.4 vs.  2.0&nbsp;&pm;&nbsp;0.3; p &equals; 0.02). The
adjusted odds ratio for angular stomatitis and low
ribo&shy;flavin status was 5.1 (95% CI:&nbsp;1.55,&nbsp;16.5)

<span data-tippy-content="Blanck, H. M., Bowman, B. A., Serdula, M. K., Khan, L. K., Kohn, W., Woodruff, B. A., & Bhutanese Refugee Investigation Group (2002). Angular stomatitis and riboflavin status among adolescent Bhutanese refugees living in southeastern Nepal. The American journal of clinical nutrition, 76(2), 430–435.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12145018/"
target="right" >Blanck et&nbsp;al., 2002</a>).  </span>
<p>
In addition, a large cross-sectional study of Irish older
adults showed that ribo&shy;flavin deficiency (EGR&nbsp;AC &gt;&nbsp;1.46) was independently associated with an increased risk of depression after adjustment for
covariates (OR 1.56, 95% CI: 1.10,&nbsp;2.00,&nbsp; p&equals;0.012)

<span data-tippy-content="Moore, K., Hughes, C. F., Hoey, L., Ward, M., Cunningham, C., Molloy, A. M., Strain, J. J., McCarroll, K., Casey, M. C., Tracey, F., Laird, E., O'Kane, M., & McNulty, H. (2019). B-vitamins in Relation to Depression in Older Adults Over 60 Years of Age: The Trinity Ulster Department of Agriculture (TUDA) Cohort Study. Journal of the American Medical Directors Association, 20(5), 551–557.e1.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/30692033/"
target="right" >Moore et&nbsp;al., 2019</a>).  </span>


<h3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Factors affecting EGR&nbsp;AC values</h3>

<b>FAD concen&shy;trations</b> used in the assay to stimulate
EGR can affect the EGR&nbsp;AC values obtained.
Concen&shy;trations of FAD &gt;&nbsp;5&micro;mol result in lower
normal ranges of EGR&nbsp;ACs, in comparison with FAD
concen&shy;trations ranging from 1&ndash;3&micro;mol

<span data-tippy-content="Garry, P. J., & Owen, G. M. (1976). An automated flavin adenine dinucleotide-dependent glutathione reductase assay for assessing riboflavin nutriture. The American journal of clinical nutrition, 29(6), 663–674.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/5881/"
target="right" >Garry and Owen, 1976</a>;  </span>

<span data-tippy-content="Rutishauser, I. H., Bates, C. J., Paul, A. A., Black, A. E., Mandal, A. R., & Patnaik, B. K. (1979). Long-term vitamin status and dietary intake of healthy elderly subjects. 1. Riboflavin. The British journal of nutrition, 42(1), 33–42.">
<a href="https://pubmed.ncbi.nlm.nih.gov/486392/"
target="right" >Rutishauser et&nbsp;al., 1979</a>;  </span>

<span data-tippy-content="Hill, M. H., Bradley, A., Mushtaq, S., Williams, E. A., & Powers, H. J. (2009). Effects of methodological variation on assessment of riboflavin status using the erythrocyte glutathione reductase activation coefficient assay. The British journal of nutrition, 102(2), 273–278.">
<a href="https://pubmed.ncbi.nlm.nih.gov/19102813/"
target="right" >Hill et&nbsp;al., 2009</a>).  </span>

<p>
<b>The length of the pre-incubation of reagents with
EGR enzyme</b> appears also to be critical.
A&nbsp;short pre-incubation period could underestimate EGR&nbsp;AC
values because less time is available for FAD to
bind to the enzyme in the hemolysate

<span data-tippy-content="Thurnham, D. I., & Rathakette, P. (1982). Incubation of NAD(P)H2: glutathione oxidoreductase (EC 1.6.4.2) with flavin adenine dinucleotide for maximal stimulation in the measurement of riboflavin status. The British journal of nutrition, 48(3), 459–466.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7171534/"
target="right" >Thurnham and Rathakette, 1982</a>).  </span>

Hill et&nbsp;al.

<span data-tippy-content="Hill, M. H., Bradley, A., Mushtaq, S., Williams, E. A., & Powers, H. J. (2009). Effects of methodological variation on assessment of riboflavin status using the erythrocyte glutathione reductase activation coefficient assay. The British journal of nutrition, 102(2), 273–278.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/19102813/"
target="right" >2009</a>)  </span>

found that 30min would be the optimal length of the pre-incubation.
<p>
<b>Age of erythrocytes</b> may also influence the EGR
activity

<span data-tippy-content="Powers, H. J., & Thurnham, D. I. (1981). Riboflavin deficiency in man: effects on haemoglobin and reduced glutathione in erythrocytes of different ages. The British journal of nutrition, 46(2), 257–266.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7284295/"
target="right" >Powers and Thurnham, 1981</a>)  </span>

 as concen&shy;trations are declining with the aging of the cells.
<p>
<b>Age of the subjects</b> may affect the EGR activity. In
some early studies a trend toward higher EGR&nbsp;ACs
with increasing age, irrespective of sex, has been
observed

<span data-tippy-content="Garry, P. J., Goodwin, J. S., & Hunt, W. C. (1982). Nutritional status in a healthy elderly population: riboflavin. The American journal of clinical nutrition, 36(5), 902–909.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7137074/"
target="right" >Garry et&nbsp;al., 1982</a>;  </span>

<span data-tippy-content="Wright, A. J., Southon, S., Bailey, A. L., Finglas, P. M., Maisey, S., & Fulcher, R. A. (1995). Nutrient intake and bio&shy;chemical status of non-instutionalized elderly subjects in Norwich: comparison with younger adults and adolescents from the same general community. The British journal of nutrition, 74(4), 453–475.">
<a href="https://pubmed.ncbi.nlm.nih.gov/7577886/"
target="right" >Wright et&nbsp;al., 1995</a>).  </span>

However, more recent investigations including the
UK population-based survey, have reported
consistently higher EGR&nbsp;AC values in younger
compared with older adults

<span data-tippy-content="Bates B, Cox L, Nicholson S, Page P, Prentice A, Steer T, Swan G. (2016). National Diet and Nutrition Survey Results from Years 5 and 6 (combined) of the Rolling Programme (2012/2013 – 2013/2014). A&nbsp;survey carried out on behalf of the Department of Health and the Food Standards Agency. [Accessed: January 2021 at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf ]">
(<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf"
target="right" >Bates et&nbsp;al., 2016</a>;  </span>

<span data-tippy-content="García-Minguillán, C. J., Fernandez-Ballart, J. D., Ceruelo, S., Ríos, L., Bueno, O., Berrocal-Zaragoza, M. I., Molloy, A. M., Ueland, P. M., Meyer, K., & Murphy, M. M. (2014). Riboflavin status modifies the effects of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) poly&shy;morphisms on homo&shy;cysteine. Genes & nutrition, 9(6), 435.">
<a href="https://pubmed.ncbi.nlm.nih.gov/25322900/"
target="right" >García-Minguillán et&nbsp;al., 2014</a>;  </span>

<span data-tippy-content="Jungert, A., McNulty, H., Hoey, L., Ward, M., Strain, J. J., Hughes, C. F., McAnena, L., Neuhäuser-Berthold, M., & Pentieva, K. (2020). Riboflavin Is an Important Determinant of Vitamin&nbsp;B-6 Status in Healthy Adults. The Journal of nutrition, 150(10), 2699–2706.">
<a href="https://pubmed.ncbi.nlm.nih.gov/32805038/"
target="right" >Jungert et&nbsp;al., 2020</a>).  </span>

It is unknown whether this difference in ribo&shy;flavin status
with age can be explained only by variations in dietary ribo&shy;flavin intake.
<p>
<b>Genetic disturbances,</b> including glucose&#8209;6-phosphate
dehydrog&shy;enase deficiency and
hetero&shy;zygous &beta;&#8209;thalassemia, are associated with disorders in
erythrocyte flavin metab&shy;olism

<span data-tippy-content="Prentice, A. M., Bates, C. J., Prentice, A., Welch, S. G., Williams, K., & McGregor, I. A. (1981). The influence of G-6-PD activity on the response of erythrocyte glutathione reductase to riboflavin deficiency. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 51(3), 211–215.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7319720/"
target="right" >Prentice et&nbsp;al., 1981</a>;  </span>

<span data-tippy-content="Anderson, B. B., Clements, J. E., Perry, G. M., Studds, C., Vullo, C., & Salsini, G. (1987). Glutathione reductase activity and its relationship to pyri&shy;dox&shy;ine phosphate activity in G6PD deficiency. European journal of haematology, 38(1), 12–20.">
<a href="https://pubmed.ncbi.nlm.nih.gov/3582603/"
target="right" >Anderson et&nbsp;al., 1987</a>;  </span>

<span data-tippy-content="Anderson, B. B., Giuberti, M., Perry, G. M., Salsini, G., Casadio, I., & Vullo, C. (1993). Low red blood cell glutathione reductase and pyri&shy;dox&shy;ine phosphate oxidase activities not related to dietary riboflavin: selection by malaria?. The American journal of clinical nutrition, 57(5), 666–672.">
<a href="https://pubmed.ncbi.nlm.nih.gov/8480684/"
target="right" >1993</a>),  </span>

which can result in misleading EGR&nbsp;AC test results. For example, in
cases of glucose&#8209;6-phosphate dehy&shy;drogenase
deficiency, there is increased avidity of the EGR for
FAD, resulting in EGR&nbsp;AC values within the normal
range, even in the presence of clinical signs of
ribo&shy;flavin deficiency

<span data-tippy-content="Thurnham D. I. (1972). Influence of glucose-6-phosphate dehy&shy;drogenase deficiency on the glutathione reductase test for ariboflavinosis. Annals of tropical medicine and parasitology, 66(4), 505–508.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/4656452/"
target="right" >Thurnham, 1972</a>).  </span>

Glucose&#8209;6-phosphate dehy&shy;drogenase deficiency is one of the
most common enzyme defects in humans and it is
highly prevalent among populations in
malaria-endemic areas of sub-Saharan Africa and the Middle
East where approximately up to 7.5% of people are
affected

<span data-tippy-content="Nkhoma, E. T., Poole, C., Vannappagari, V., Hall, S. A., & Beutler, E. (2009). The global prevalence of glucose-6-phosphate dehy&shy;drogenase deficiency: a systematic review and meta-analysis. Blood cells, molecules & diseases, 42(3), 267–278.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/19233695/"
target="right" >Nkhoma et&nbsp;al., 2009</a>).  </span>

It is estimated that glucose&#8209;6-phosphate dehy&shy;drogenase deficiency occurs
in around 10% of Americans of African descent

<span data-tippy-content="Frischer, H., Bowman, J. E., Carson, P. E., Rieckmann, K. H., Willerson, D., Jr, & Colwell, E. J. (1973). Erythrocytic glutathione reductase, glucose-6-phosphate dehy&shy;drogenase, and 6-phosphogluconic dehy&shy;drogenase deficiencies in populations of the United States, South Vietnam, Iran, and Ethiopia. The Journal of laboratory and clinical medicine, 81(4), 603–612.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/4696191/"
target="right" >Frischer et&nbsp;al., 1973</a>).  </span>

In contrast, in hetero&shy;zygous &beta;&#8209;thalassemia, there is an inherited slow red-cell
metab&shy;olism of ribo&shy;flavin to FMN and FAD and a high
stimulation of the erythrocyte glutathionine reductase by extraneous FAD

<span data-tippy-content="Anderson, B. B., Giuberti, M., Perry, G. M., Salsini, G., Casadio, I., & Vullo, C. (1993). Low red blood cell glutathione reductase and pyri&shy;dox&shy;ine phosphate oxidase activities not related to dietary riboflavin: selection by malaria?. The American journal of clinical nutrition, 57(5), 666–672.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/8480684/"
target="right" >Anderson et&nbsp;al., 1993</a>).  </span>
<p>
<b>Pyri&shy;dox&shy;ine deficiency</b> also interferes with the EGR
AC test, resulting in a decreased erythrocyte
glutathione reductase activity but no change in the
activity coefficient, probably arising from a decrease
in apoenzyme. No comparable effects have been
observed for other vitamin deficiencies such as
thiamin and vitamin&nbsp;C.
<p>
<b>Disease states,</b> including iron-deficiency anemia

<span data-tippy-content="Ramachandran, M., & Iyer, G. Y. (1974). Erythrocyte glutathione reductase in iron deficiency anaemia. Clinica chimica acta; international journal of clinical chemistry, 52(2), 225–229. ">
(<a href="https://pubmed.ncbi.nlm.nih.gov/4828232/"
target="right" >Ramachandran and Iyer, 1974</a>),  </span>

severe uremia, cirrhosis of the liver, and hypothyroidism lead to
increased erythrocyte glutathione reductase activity.
<p>
<b>Conditions of negative nitrogen balance</b> lead to a
fall in EGR&nbsp;AC values. In pregnant women in The
Gambia, for example, EGR&nbsp;AC values fell in
association with a decline in body weight during the
rainy season, despite evidence that malnutrition had
actually increased

<span data-tippy-content="Bates, C. J., Prentice, A. M., Paul, A. A., Sutcliffe, B. A., Watkinson, M., & Whitehead, R. G. (1981). Riboflavin status in Gambian pregnant and lactating women and its implications for Recommended Dietary Allowances. The American journal of clinical nutrition, 34(5), 928–935.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7234718/"
target="right" >Bates et&nbsp;al., 1981</a>).  </span>

Similar findings have been reported in preschool children with
upper respiratory tract infections and measles

<span data-tippy-content="Bamji, M. S., Bhaskaram, P., & Jacob, C. M. (1987). Urinary riboflavin excretion and erythrocyte glutathione reductase activity in preschool children suffering from upper respiratory infections and measles. Annals of nutrition & metab&shy;olism, 31(3), 191–196.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/3592624/"
target="right" >Bamji et&nbsp;al., 1987</a>).  </span>

<h3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interpretive criteria</h3>

There is still uncertainty regarding the most
appropriate threshold value indicative of normal
ribo&shy;flavin status. An EGR&nbsp;AC value of &lt;&nbsp;1.3 is
generally considered to represent saturation of the
tissues with ribo&shy;flavin. This value was derived from
the ribo&shy;flavin depletion-repletion study in young men
(<a href="#figure20b.2">Figure&nbsp;20b.2</a>) as well as
from the supple&shy;mentation study in elderly people with
ribo&shy;flavin deficiency

<span data-tippy-content="Boisvert, W. A., Mendoza, I., Castañeda, C., De Portocarrero, L., Solomons, N. W., Gershoff, S. N., & Russell, R. M. (1993). Riboflavin requirement of healthy elderly humans and its relationship to macronutrient composition of the diet. The Journal of nutrition, 123(5), 915–925.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/8487103/"
target="right" >Boisvert et&nbsp;al., 1993b</a>)  </span>

where urinary excretion of ribo&shy;flavin started to increase
sharply (a point reflecting body saturation) at
EGR&nbsp;AC below 1.3. A&nbsp;systematic review including
18&nbsp;supple&shy;mentation studies concluded that a cut-off
of&nbsp;1.3 should be considered as the &ldquo;upper limit of a normal
range&rdquo;

<span data-tippy-content="Hoey, L., McNulty, H., & Strain, J. J. (2009). Studies of bio&shy;marker responses to intervention with riboflavin: a systematic review. The American journal of clinical nutrition, 89(6), 1960S–1980S.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/19403631/"
target="right" >Hoey et&nbsp;al., 2009</a>).  </span>
Sadowski
<span data-tippy-content="Sadowski JA. (1992).	Riboflavin. In: Hartz SC, Russell RM, Rosenberg IH (eds.) Nutrition in the Elderly.  The Boston Nutritional Status Survey. Smith-Gordon, London, pp. 119–125.">
<a href="http://www.fao.org/3/Y2809E/y2809e09.htm"
target="right" >1992</a>)</span>,

however, used an upper limit of 1.34 in a study of apparently
healthy elderly. This value was based on the mean
plus 2&nbsp;SD of the EGR&nbsp;AC value derived from a large
sample of Boston elderly aged &ge;&nbsp;60y. Cutoff
EGR&nbsp;AC values of 1.3&ndash;1.4 for suboptimal and &gt;&nbsp;1.4
for deficiency states are often used

<span data-tippy-content="Wilson, C. P., McNulty, H., Ward, M., Strain, J. J., Trouton, T. G., Hoeft, B. A., Weber, P., Roos, F. F., Horigan, G., McAnena, L., & Scott, J. M. (2013). Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial. Hypertension (Dallas, Tex. : 1979), 61(6), 1302–1308.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/23608654/"
target="right" >Wilson et&nbsp;al., 2013</a>;  </span>

<span data-tippy-content="Whitfield, K. C., Karakochuk, C. D., Liu, Y., McCann, A., Talukder, A., Kroeun, H., Ward, M., McNulty, H., Lynd, L. D., Kitts, D. D., Li-Chan, E. C., McLean, J., & Green, T. J. (2015). Poor thiamin and riboflavin status is common among women of childbearing age in rural and urban Cambodia. The Journal of nutrition, 145(3), 628–633.">
<a href="https://pubmed.ncbi.nlm.nih.gov/25733481/"
target="right" >Whitfield et&nbsp;al., 2015</a>;  </span>

<span data-tippy-content="Aljaadi, A. M., How, R. E., Loh, S. P., Hunt, S. E., Karakochuk, C. D., Barr, S. I., McAnena, L., Ward, M., McNulty, H., Khor, G. L., Devlin, A. M., & Green, T. J. (2019). Suboptimal Biochemical Riboflavin Status Is Associated with Lower Hemoglobin and Higher Rates of Anemia in a Sample of Canadian and Malaysian Women of Reproductive Age. The Journal of nutrition, 149(11), 1952–1959.">
<a href="https://pubmed.ncbi.nlm.nih.gov/31318024/"
target="right" >Aljaadi et&nbsp;al., 2019</a>;  </span>

<span data-tippy-content="Jungert, A., McNulty, H., Hoey, L., Ward, M., Strain, J. J., Hughes, C. F., McAnena, L., Neuhäuser-Berthold, M., & Pentieva, K. (2020). Riboflavin Is an Important Determinant of Vitamin&nbsp;B-6 Status in Healthy Adults. The Journal of nutrition, 150(10), 2699–2706.">
<a href="https://pubmed.ncbi.nlm.nih.gov/32805038/"
target="right" >Jungert et&nbsp;al., 2020</a>);  </span>

these cutoffs appear to be independent of sex. Generally, EGR&nbsp;AC values in the
range from 1.5 to 2.5 were found in population groups
consuming very low intakes of ribo&shy;flavin, wih
evidence of clinical ribo&shy;flavin deficiency

<span data-tippy-content="Bates, C. J., Prentice, A. M., Paul, A. A., Sutcliffe, B. A., Watkinson, M., & Whitehead, R. G. (1981). Riboflavin status in Gambian pregnant and lactating women and its implications for Recommended Dietary Allowances. The American journal of clinical nutrition, 34(5), 928–935.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7234718/"
target="right" >Bates et&nbsp;al., 1981</a>;  </span>

<span data-tippy-content="Thurnham, D. I., Rathakette, P., Hambidge, K. M., Munoz, N., & Crespi, M. (1982). Riboflavin, vitamin&nbsp;A and zinc status in Chinese subjects in a high-risk area for oesophageal cancer in China. Human nutrition. Clinical nutrition, 36(5), 337–349.">
<a href="https://pubmed.ncbi.nlm.nih.gov/7174357/"
target="right" >Thurnham et&nbsp;al., 1982</a>;  </span>

<span data-tippy-content="Lo C. S. (1985). Riboflavin status of adolescent southern Chinese: riboflavin saturation studies. Human nutrition. Clinical nutrition, 39(4), 297–301.">
<a href="https://pubmed.ncbi.nlm.nih.gov/4044294/"
target="right" >Lo, 1985</a>).  </span>

In a study of adolescent Bhutanese refugees, Blanck et&nbsp;al.

<span data-tippy-content="Blanck, H. M., Bowman, B. A., Serdula, M. K., Khan, L. K., Kohn, W., Woodruff, B. A., & Bhutanese Refugee Investigation Group (2002). Angular stomatitis and riboflavin status among adolescent Bhutanese refugees living in southeastern Nepal. The American journal of clinical nutrition, 76(2), 430–435.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12145018/"
target="right" >2002</a>)  </span>

used an EGR&nbsp;AC cutoff of &gt;&nbsp;1.7, and based on
this value, 86% had low ribo&shy;flavin status.
<p></p>
Considering that various methods for EGR&nbsp;AC
assessment generate slightly different
results

<span data-tippy-content="Hill, M. H., Bradley, A., Mushtaq, S., Williams, E. A., & Powers, H. J. (2009). Effects of methodological variation on assessment of riboflavin status using the erythrocyte glutathione reductase activation coefficient assay. The British journal of nutrition, 102(2), 273–278.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/19102813/"
target="right" >Hill et&nbsp;al., 2009</a>), </span>

it is reasonable to expect that the cutoff
value would be dependent on the analytical method
used; thus, reference ranges developed in the local
laboratories should be considered.
<p></p>
<table>
<caption class="cap">
Table&nbsp;20b.3:  Median and 97.5<sup>th</sup> percentile values for
the activity coefficient (AC) of erythrocyte glutathione
reductase (EGR) in UK adults by age and sex. Data from
Bates et&nbsp;al.
<span data-tippy-content="Bates B, Cox L, Nicholson S, Page P, Prentice A, Steer T, Swan G. (2016). National Diet and Nutrition Survey Results from Years 5 and 6 (combined) of the Rolling Programme (2012/2013 – 2013/2014). A&nbsp;survey carried out on behalf of the Department of Health and the Food Standards Agency.">
(<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf"
target="right" >2016</a>).  </span>

</caption>
<thead style="font-size: 18px; background-color: lavender;">
<tr><th><th  colspan="2"> EGR activity coefficient</th>
<tr> <th><th>19&ndash;64y<th>&ge;&nbsp;65y</th>
</thead>
<tbody style="font-size: 15px">
<tr><td>Men  Median <td> 1.31 <td>1.26
<tr><td>   97.5<sup>th</sup> percentile <td> 1.99 <td> 1.61
<tr><td><td><td>
<tr><td>Women   Median <td> 1.33 <td> 1.28
<tr><td>   97.5<sup>th</sup> percentile<td> 1.94 <td> 1.71
</tr>
</tbody>
</table>
Information on the EGR activity coefficients from the
UK National Dietary Nutrition Survey Rolling
Programme, which includes data for all age groups
split by sex is available

<span data-tippy-content="Bates B, Cox L, Nicholson S, Page P, Prentice A, Steer T, Swan G. (2016). National Diet and Nutrition Survey Results from Years 5 and 6 (combined) of the Rolling Programme (2012/2013 – 2013/2014). A&nbsp;survey carried out on behalf of the Department of Health and the Food Standards Agency.">
(<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf"
target="right" >Bates et&nbsp;al, 2016</a>).  </span>

The median and upper 2.5<sup>th</sup> percentile of the adult
population by age and sex are presented in
<a href="#table20b.3">Table&nbsp;20b.3</a>
<a id="table20b.3"></a>

<h3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Measurement of erythrocyte glutathionine reductase activity</h3>

Only small samples of blood are required for the EGR
assay, and fasting samples are not necessary

<span data-tippy-content="Komindr S, Nichoalds GE. (1980). Clinical significance of riboflavin deficiency. In: Brewster MA, Naito HK (eds.) Nutritional Elements and Clinical Biochemistry. Plenum Press, New York, pp. 15–68.">
(<a href="https://link.springer.com/book/10.1007/978-1-4613-3168-1?error=cookies_not_supported&code=b8e3e522-a037-468e-9a64-1f573eda54fd"
target="right" >Komindr and Nichoalds, 1980</a></span>).

Either EDTA or heparin can be used as an anti&shy;coagulant. Erythro&shy;cytes
must be washed and lysed, and the assay must be
performed immediately after blood samples are drawn
because FAD is a labile compound

<span data-tippy-content="
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics
5th Edition
 Elsevier; 2016:chap 31. Shenkin A, Roberts NB. Vitamins and trace elements.
 *** NOT ON MEDLINE ***">
(<a href=""
target="right" >Shenkin and Roberts, 2016</a></span>).

Alternatively, the hemolyzed samples
can be kept frozen for over a year at &minus;70&deg;C without
loss of EGR activity.
<p>
Generally, glutathione reductase activity is measured
using an enzyme-coupled kinetic assay, although
some colorimetric methods are also available

<span data-tippy-content="Sauberlich H. E. (1984). Newer laboratory methods for assessing nutriture of selected B-complex vitamins. Annual review of nutrition, 4, 377–407.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/6235828/"
target="right" >Sauberlich, 1984</a>).  </span>

An automated method involving the use of a centrifugal analyzer has been developed

<span data-tippy-content="Mak, Y. T., & Swaminathan, R. (1988). Assessment of vitamin&nbsp;B1, B2&nbsp;and B6&nbsp;status by coenzyme activation of red cell enzymes using a centrifugal analyser. Journal of clinical chemistry and clinical bio&shy;chemistry. Zeitschrift fur klinische Chemie und klinische Biochemie, 26(4), 213–217.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/3404087/"
target="right" >Mak and Swaminathan, 1988</a>;  </span>

<span data-tippy-content="La Rue, A., Koehler, K. M., Wayne, S. J., Chiulli, S. J., Haaland, K. Y., & Garry, P. J. (1997). Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. The American journal of clinical nutrition, 65(1), 20–29.">
<a href="https://pubmed.ncbi.nlm.nih.gov/8988908/"
target="right" >La Rue et&nbsp;al., 1997</a>).  </span>

An alternative procedure, using well plates and a plate
reader, has also been described

<span data-tippy-content="Sauberlich HE. (1999). Laboratory Tests for the Assessment of Nutritional Status. CRC Press, Boca Raton, FL.">
(<a href="https://www.taylorfrancis.com/books/mono/10.1201/9780203749647/laboratory-tests-assessment-nutritional-status-howerde-sauberlich"
target="right" >Sauberlich, 1999</a></span>).

Very small volumes of whole blood instead of
erythrocytes can be used for the measurement of
glutathionine reductase activity, but the method,
although simpler, is less sensitive. Care must be taken
to ensure that the protocols for the assay are carefully
specified and followed so that results can be
compared among studies. As noted previously, the
EGR assay is invalid for persons with glucose&#8209;6-
phosphate dehy&shy;drogen&shy;ase deficiency.

<h3 id="20b.2.2">20b.2.2 Urinary ribo&shy;flavin excretion</h3>

Flavins are excreted in urine mainly in the form of
ribo&shy;flavin (60&ndash;70% of all urinary flavins) or other
metabolites, such as 7&#8209;hydroxy&shy;methyl&shy;ribo&shy;flavin
(7&#8209;&alpha;-hydroxy&shy;ribo&shy;flavin) and lumi&shy;flavin

<span data-tippy-content="Chastain, J. L., & McCormick, D. B. (1987). Flavin catabolites: identification and quantitation in human urine. The American journal of clinical nutrition, 46(5), 830–834.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/3673930/"
target="right" >Chastain and McCormick, 1987</a>).  </span>

Very little ribo&shy;flavin can be
stored in the body, so urinary excretion reflects
dietary intake after tissues become saturated.
A&nbsp;strong positive linear correlation of urinary ribo&shy;flavin
with ribo&shy;flavin intake above 1.4mg/day has been reported
(r<sup>2</sup> &equals; 0.9667, p &lt;&nbsp;0.01)

<span data-tippy-content="Guo, C., Wei, J., Gao, W., Pu, L., Tang, Z., & Li, L. (2016). Plasma riboflavin is a useful marker for studying riboflavin requirement in Chinese male adults. Nutrition research (New York, N.Y.), 36(6), 534–540.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/27188899/"
target="right" >Guo et&nbsp;al., 2016</a>).  </span>

Urinary ribo&shy;flavin excretion is considered a bio&shy;marker of short-term status.
<p></p>
Experimental balance studies indicate that urinary
ribo&shy;flavin excretionary rates increase slowly with
increasing intakes until the point of tissue saturation,
after which any further increase of ribo&shy;flavin intake
leads to a sharp elevation of the excretion rate, as
shown in
<a href="#figure20b.3">Figure&nbsp;20b.3</a>.
<a id="figure20b.3"></a>	
<figure style="width: 50%">
<img src="figures/fig20b.3.jpg" class="hundred" alt="Figure20b.3">
<figcaption class="cap">	
Figure&nbsp;20b.3:  Relationship of riboflavin intake to urinary
excretion. Redrawn from Sauberlich
<span data-tippy-content="Sauberlich HE. (1999). Laboratory Tests for the Assessment of Nutritional Status. CRC Press, Boca Raton, FL.">
(<a href="https://www.taylorfrancis.com/books/mono/10.1201/9780203749647/laboratory-tests-assessment-nutritional-status-howerde-sauberlich"
target="right" >1999</a></span>).
</figcaption>
</figure>
Based on the weighted results of experimental studies

<span data-tippy-content="Brewer, W., & Porter, T. (1946). The urinary excretion of riboflavin by college women. The Journal of nutrition, 32(6), 583–596.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/20277355/"
target="right" >Brewer et&nbsp;al., 1946</a>;  </span>

<span data-tippy-content="Horwitt, M. K., Harvey, C. C., Hills, O. W., & Liebert, E. (1950). Correlation of urinary excretion of riboflavin with dietary intake and symptoms of ariboflavinosis. The Journal of nutrition, 41(2), 247–264.">
<a href="https://pubmed.ncbi.nlm.nih.gov/15422413/"
target="right" >Horwitt et&nbsp;al., 1950</a>;  </span>

<span data-tippy-content="Boisvert, W. A., Mendoza, I., Castañeda, C., De Portocarrero, L., Solomons, N. W., Gershoff, S. N., & Russell, R. M. (1993). Riboflavin requirement of healthy elderly humans and its relationship to macronutrient composition of the diet. The Journal of nutrition, 123(5), 915–925.">
<a href="https://pubmed.ncbi.nlm.nih.gov/8487103/"
target="right" >Boisvert et&nbsp;al., 1993b</a>;  </span>

<span data-tippy-content="Guo, C., Wei, J., Gao, W., Pu, L., Tang, Z., & Li, L. (2016). Plasma riboflavin is a useful marker for studying riboflavin requirement in Chinese male adults. Nutrition research (New York, N.Y.), 36(6), 534–540.">
<a href="https://pubmed.ncbi.nlm.nih.gov/27188899/"
target="right" >Guo et&nbsp;al., 2016</a>),  </span>

the European Food Safety Authority estimated
that the change of the urinary excretion rate of
ribo&shy;flavin corresponding to the point of tissue
saturation could be achieved by a ribo&shy;flavin intake of
around 1.3mg/d

<span data-tippy-content="EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), Turck, D., Bresson, J. L., Burlingame, B., Dean, T., Fairweather-Tait, S., Heinonen, M., Hirsch-Ernst, K. I., Mangelsdorf, I., McArdle, H. J., Naska, A., Nowicka, G., Pentieva, K., Sanz, Y., Siani, A., Sjödin, A., Stern, M., Tomé, D., Van Loveren, H., Vinceti, M., … Neuhäuser-Berthold, M. (2017). Dietary Reference Values for riboflavin. EFSA journal. European Food Safety Authority, 15(8), e04919.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/32625611/"
target="right" >EFSA, 2017</a>).  </span>

Once intakes of 2.5mg/d are reached, excretion becomes approximately
equal to the rate of absorption

<span data-tippy-content="Horwitt, M. K., Harvey, C. C., Hills, O. W., & Liebert, E. (1950). Correlation of urinary excretion of riboflavin with dietary intake and symptoms of ariboflavinosis. The Journal of nutrition, 41(2), 247–264.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/15422413/"
target="right" >Horwitt et&nbsp;al., 1950</a>).  </span>

At such high intakes, a significant proportion of the
ribo&shy;flavin intake is not absorbed.
<p>
Urinary ribo&shy;flavin was measured in several early
population studies in North America: the Nutrition
Canada survey, the US&nbsp;Ten State Nutrition Survey,
and in NHANES&nbsp;I. In these surveys, casual urine
samples were collected rather than the preferable
24h&nbsp;urine samples. As a result, ribo&shy;flavin concen&shy;trations
were expressed per gram of creatinine. For children,
the rate of ribo&shy;flavin excretion, when expressed per
gram of creatinine is greater than for adults. The
population-based VERA Study, conducted as part of
the German National Consumption Study I, assessed
urinary ribo&shy;flavin in 24hour urine samples of 2,006
adults

<span data-tippy-content="Heseker H, Schneider R, Moch KJ, Kohlmeier M, Kübler W. (1992). Vitaminversorgung Erwachsener in der Bundesrepublik Deutschland. VERA Schriftenreihe Band IV Wissenschaftlicher Fachverlag Dr. Fleck, Niederkleen, Germany.  &bull;&bull;&bull;NO PUBMED ENTRY&bull;&bull;&bull; ">
(<a href="https://www.google.com" target="right" >Heseker et&nbsp;al., 1992</a></span>)
<p>
Occasionally, a ribo&shy;flavin load test is used to assess
the degree to which the body is saturated with
ribo&shy;flavin. An oral dose of 5mg ribo&shy;flavin is given,
and again the timed excretion of ribo&shy;flavin in the
urine is measured, usually over a 4h period

<span data-tippy-content="Lossy, F. T., Goldsmith, G. A., & Sarett, H. P. (1951). A study of test dose excretion of five B complex vitamins in man. The Journal of nutrition, 45(2), 213–224.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/14889323/"
target="right" >Lossy et&nbsp;al., 1951</a>;  </span>

<span data-tippy-content="ICNND (Interdepartmental Committee on Nutrition for National Defense). (1963). Manual for Nutrition Surveys. 2nd ed. U.S. Government Printing Office, Washington, DC.">
<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1257008/"
target="right" >ICNND, 1963</a></span>;

<span data-tippy-content="Brun, T. A., Chen, J., Campbell, T. C., Boreham, J., Feng, Z., Parpia, B., Shen, T. F., & Li, M. (1990). Urinary riboflavin excretion after a load test in rural China as a measure of possible riboflavin deficiency. European journal of clinical nutrition, 44(3), 195–206.">
<a href="https://pubmed.ncbi.nlm.nih.gov/2369885/"
target="right" >Brun et&nbsp;al., 1990</a>);   </span>

the results
should be compared with the level in the urine before
the test load.
<p>
<h3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Factors affecting ribo&shy;flavin excretion</h3>
<p>
<b>Physical activity and sleep </b> can decrease ribo&shy;flavin
excretion

<span data-tippy-content="Soares, M. J., Satyanarayana, K., Bamji, M. S., Jacob, C. M., Ramana, Y. V., & Rao, S. S. (1993). The effect of exercise on the riboflavin status of adult men. The British journal of nutrition, 69(2), 541–551.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/8490007/"
target="right" >Soares et&nbsp;al., 1993</a>).  </span>


<p>
<b>Negative nitrogen balance and infection</b> induce a
breakdown of tissue protein and, hence, increase
urinary excretion of ribo&shy;flavin

<span data-tippy-content="Tucker, R. G., Mickelsen, O., & Keys, A. (1960). The influence of sleep, work, diuresis, heat, acute starvation, thiamine intake and bed rest on human riboflavin excretion. The Journal of nutrition, 72(2), 251–261.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/13778542/"
target="right" >Tucker et&nbsp;al., 1960</a>).  </span>


Consequently, measurement of urinary ribo&shy;flavin is
not very useful in circumstances where intakes of
protein are low or where chronic infection is common.
<p>
<b>Drugs</b> including some anti&shy;bio&shy;tics and psycho&shy;tropic
drugs such as pheno&shy;thiazines can increase the
excretion of ribo&shy;flavin

<span data-tippy-content="Goldsmith G. A. (1975). Vitamin&nbsp;B complex. Thiamine, riboflavin, niacin, folic acid (folacin), vitamin&nbsp;B12, bio&shy;tin. Progress in food & nutrition science, 1(9), 559–609.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/772756/"
target="right" >Goldsmith, 1975</a>).  </span>
<p>
<b>Oral contraceptive agents and pregnancy</b> influence
ribo&shy;flavin excretion. Concen&shy;trations decrease when
oral contraceptive agents are used, and during the
third trimester of pregnancy, as tissue retention of the
vitamin is increased in response to increased need.
However, during the second trimester, excretion increases.
<p>
<b>Within-subject variability</b> can be large for 24h
urinary ribo&shy;flavin excretion. Coefficients of variation
range from 13% to 25%, which are not reduced when
results are expressed in terms of creatinine

<span data-tippy-content="van Dokkum, W., Schrijver, J., & Wesstra, J. A. (1990). Variability in man of the levels of some indices of nutritional status over a 60-d period on a constant diet. European journal of clinical nutrition, 44(9), 665–674.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/2261898/"
target="right" >van Dokkum et&nbsp;al., 1990</a>).  </span>

<h3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interpretive criteria</h3>

Interpretive criteria for urinary ribo&shy;flavin excretion
for adults and children are shown in
<a href="#table20b.4">Table&nbsp;20b.4</a>.
<a id="table20b.4"></a>
<table>
<caption class="cap">
Table&nbsp;20b.4:  Interpretive criteria for the urinary excretion
of riboflavin.   tri:  trimester.     From
<span data-tippy-content="Sauberlich HE. (1999). Laboratory Tests for the Assessment of Nutritional Status. CRC Press, Boca Raton, FL.">
(<a href="https://www.taylorfrancis.com/books/mono/10.1201/9780203749647/laboratory-tests-assessment-nutritional-status-howerde-sauberlich"
target="right" >Sauberlich HE ,1999</a></span>).
</caption>
<thead style="font-size: 18px; background-color: lavender;">
<tr><th rowspan="2">Subjects<th  colspan="2"> Less than acceptable (at risk)<th rowspan="2">
<br>Acceptable <br>(low risk)</th>
<tr><th>Deficient <br>(high risk)<th>Suboptimal<br>(med. risk)</th>
</thead>
<tbody style="font-size: 15px">
<tr><td style="text-align:left">Children <td  colspan="3">(&micro;g/g creatinine)
<tr><td style="text-align:left">&nbsp;&nbsp;&nbsp;1&ndash;3y<td> &lt;&nbsp;150<td> 150&ndash;499<td> &ge;&nbsp;500
<tr><td style="text-align:left">&nbsp;&nbsp;&nbsp;4&ndash;6y<td> &lt;&nbsp;100<td> 100&ndash;299<td> &ge;&nbsp;300
<tr><td style="text-align:left">&nbsp;&nbsp;&nbsp;7&ndash;9y<td> &lt;&nbsp;85<td> 85&ndash;269<td> &ge;&nbsp;270
<tr><td style="text-align:left">&nbsp;&nbsp;&nbsp;10&ndash;15y<td> &lt;&nbsp;70<td> 70&ndash;199<td> &ge;&nbsp;200
<tr><td style="text-align:left">Adults<td> &lt;&nbsp;27<td> 27&ndash;79<td> &ge;&nbsp;80
<tr><td style="text-align:left">&nbsp;&nbsp;&nbsp;Preg. 1st tri.<td> &lt;&nbsp;27<td> 27&ndash;65<td> 66&ndash;129
<tr><td style="text-align:left">&nbsp;&nbsp;&nbsp;Preg. 2nd tri.<td> &lt;&nbsp;23<td> 23&ndash;54<td> 55&ndash;109
<tr><td style="text-align:left">&nbsp;&nbsp;&nbsp;Preg. 3rd tri.<td> &lt;&nbsp;21<td> 21&ndash;49<td> 50&ndash;99
<tr><td style="text-align:left">Adults <td  colspan="3">Other interpretive guidelines
<tr><td style="text-align:left">&nbsp;&nbsp;&nbsp;&micro;g/24h <td>&lt;&nbsp;40<td> 40&ndash;119<td> &ge;&nbsp;120
<tr><td style="text-align:left">&nbsp;&nbsp;&nbsp;&micro;g/6h<td> &lt;&nbsp;10<td> 10&ndash;29<td> &ge;&nbsp;30
<tr><td style="text-align:left">&nbsp;&nbsp;&nbsp;&micro;g in 4h after<br>
&nbsp;&nbsp;&nbsp;ribofl. load<td> &lt;&nbsp;1000<td> 1000&ndash;1399<td> &ge;&nbsp;1400
</tr>
</tbody>
</table>
For adults, when dietary intakes are adequate, &ge;&nbsp;120&micro;g of
ribo&shy;flavin per day should be excreted. After a loading
dose of 5mg ribo&shy;flavin, then &ge;&nbsp;1400&micro;g of ribo&shy;flavin
should be excreted in a 4h period under conditions of
adequate ribo&shy;flavin intake. In a deficiency
state, &lt;&nbsp;l000&micro;g of ribo&shy;flavin will be excreted during the same
time period. Interpretive criteria for ribo&shy;flavin
excretion in casual urine samples expressed as &micro;g/g
creatinine for children, adults, and pregnant women
are also given in <a href="#table20b.4">Table&nbsp;20b.4</a>.

<h3>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Measurement of urinary ribo&shy;flavin</h3>

In the past, fluorometric and microbio&shy;logical assays
have generally been used to determine ribo&shy;flavin
concen&shy;trations in urine. The fluorometric method
measures the fluorescence of the flavins directly or
converts the flavins to lumiflavin and then determines
the fluorescence. The microbio&shy;logical methods use
<i>Ochromonas danica</i> or the protozoan <i>Tetrahymena
pyriformis.</i>
<p>
Measurement of urinary ribo&shy;flavin using HPLC with
fluorometry

<span data-tippy-content="Gatautis, V. J., & Naito, H. K. (1981). Liquid-chromatographic determination of urinary riboflavin. Clinical chemistry, 27(10), 1672–1675.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7285318/"
target="right" >Gatautis and Naito, 1981</a>)  </span>

or competitive protein-binding assays

<span data-tippy-content="Tillotson, J. A., & Bashor, M. M. (1980). Fluorometric apoprotein titration of urinary riboflavin. Analytical bio&shy;chemistry, 107(1), 214–219.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/6776843/"
target="right" >Tillotson and Bashor, 1980</a>)  </span>

is also possible. The protein-binding assays are rapid,
sensitive, and require no treatment of the urine sample
prior to analysis. Discrepancies among the analytical
methods have been documented. Results for the
HPLC method with fluorometry tend to be lower than
those with the older fluorometric method alone
because, in the HPLC method, ribo&shy;flavin is separated
from other flavins

<span data-tippy-content="Smith M. D. (1980). Rapid method for determination of riboflavin in urine by high-performance liquid chromatography. Journal of chromatography, 182(3-4), 285–291.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/7391169/"
target="right" >Smith, 1980</a>).  </span>

<h3 id="20b.2.3">20b.2.3 Ribo&shy;flavin, FMN and FAD in blood</h3>

Plasma or serum concentration of ribo&shy;flavin and its
derivatives, FMN and FAD have been used in a few
studies for assessment of ribo&shy;flavin status. The results
of these investigations showed that supple&shy;mentation
with low doses of ribo&shy;flavin increased plasma free
ribo&shy;flavin

<span data-tippy-content="Bessey, O. A., Horwitt, M. K., & Love, R. H. (1956). Dietary deprivation of riboflavin and blood riboflavin levels in man. The Journal of nutrition, 58(3), 367–383.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/13307309/"
target="right" >Bessey et&nbsp;al., 1956</a>;  </span>

<span data-tippy-content="Hustad, S., McKinley, M. C., McNulty, H., Schneede, J., Strain, J. J., Scott, J. M., & Ueland, P. M. (2002). Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supple&shy;mentation. Clinical chemistry, 48(9), 1571–1577.">
<a href="https://pubmed.ncbi.nlm.nih.gov/12194936/"
target="right" >Hustad et&nbsp;al., 2002</a>;  </span>

<span data-tippy-content="Guo, C., Wei, J., Gao, W., Pu, L., Tang, Z., & Li, L. (2016). Plasma riboflavin is a useful marker for studying riboflavin requirement in Chinese male adults. Nutrition research (New York, N.Y.), 36(6), 534–540.">
<a href="https://pubmed.ncbi.nlm.nih.gov/27188899/"
target="right" >Guo et&nbsp;al., 2016</a>)  </span>

 and FMN

<span data-tippy-content="Bessey, O. A., Horwitt, M. K., & Love, R. H. (1956). Dietary deprivation of riboflavin and blood riboflavin levels in man. The Journal of nutrition, 58(3), 367–383.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/13307309/"
target="right" >Bessey et&nbsp;al., 1956</a>;  </span>

<span data-tippy-content="Hustad, S., McKinley, M. C., McNulty, H., Schneede, J., Strain, J. J., Scott, J. M., & Ueland, P. M. (2002). Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supple&shy;mentation. Clinical chemistry, 48(9), 1571–1577.">
<a href="https://pubmed.ncbi.nlm.nih.gov/12194936/"
target="right" >Hustad et&nbsp;al., 2002</a>)  </span>


whereas no detectable or very
modest changes were reported for plasma FAD
concen&shy;trations

<span data-tippy-content="Bessey, O. A., Horwitt, M. K., & Love, R. H. (1956). Dietary deprivation of riboflavin and blood riboflavin levels in man. The Journal of nutrition, 58(3), 367–383.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/13307309/"
target="right" >Bessey et&nbsp;al., 1956</a>;  </span>

<span data-tippy-content="Zempleni, J., Galloway, J. R., & McCormick, D. B. (1996). Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. The American journal of clinical nutrition, 63(1), 54–66.">
<a href="https://pubmed.ncbi.nlm.nih.gov/8604671/"
target="right" >Zempleni et&nbsp;al., 1996</a>;  </span>

<span data-tippy-content="Hustad, S., McKinley, M. C., McNulty, H., Schneede, J., Strain, J. J., Scott, J. M., & Ueland, P. M. (2002). Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supple&shy;mentation. Clinical chemistry, 48(9), 1571–1577.">
<a href="https://pubmed.ncbi.nlm.nih.gov/12194936/"
target="right" >Hustad et&nbsp;al., 2002</a>).  </span>

<p>
The concentration of ribo&shy;flavin forms in erythrocytes
could be considered as marker of long-term
ribo&shy;flavin intake. Erythrocyte concentration of
ribo&shy;flavin (mainly FMN and FAD) was found to be
significantly lower in individuals with clinical signs of
ribo&shy;flavin deficiency compared with healthy people

<span data-tippy-content="Bamji M. S. (1969). Glutathione reductase activity in red blood cells and riboflavin nutritional status in humans. Clinica chimica acta; international journal of clinical chemistry, 26(2), 263–269.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/5352698/"
target="right" >Bamji, 1969</a>).  </span>

Supple&shy;mentation with a low dose of
ribo&shy;flavin for 12wks increased erythrocyte FMN by
87% whereas more modest but still significant
response was reported for erythrocyte FAD

<span data-tippy-content="Hustad, S., McKinley, M. C., McNulty, H., Schneede, J., Strain, J. J., Scott, J. M., & Ueland, P. M. (2002). Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supple&shy;mentation. Clinical chemistry, 48(9), 1571–1577.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12194936/"
target="right" >Hustad et&nbsp;al., 2002</a>).  </span>

A&nbsp;good relationship was shown between
EGR&nbsp;AC and erythrocyte ribo&shy;flavin

<span data-tippy-content="Bates, C. J., Prentice, A., Cole, T. J., van der Pols, J. C., Doyle, W., Finch, S., Smithers, G., & Clarke, P. C. (1999). Micronutrients: highlights and research challenges from the 1994-5 National Diet and Nutrition Survey of people aged 65 years and over. The British journal of nutrition, 82(1), 7–15.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/10655951/"
target="right" >Bates et&nbsp;al., 1999</a>)  </span>

 and erythrocyte FMN and FAD

<span data-tippy-content="Hustad, S., McKinley, M. C., McNulty, H., Schneede, J., Strain, J. J., Scott, J. M., & Ueland, P. M. (2002). Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supple&shy;mentation. Clinical chemistry, 48(9), 1571–1577.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12194936/"
target="right" >Hustad et&nbsp;al., 2002</a>)  </span>

indicating that these measurements have
potential and warrant further exploration.
<p>
Fluorometric and microbio&shy;logical assays have been
used to determine ribo&shy;flavin in plasma / serum and
erythrocytes.
Hustad et&nbsp;al.

<span data-tippy-content="Hustad, S., Ueland, P. M., & Schneede, J. (1999). Quantification of riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma by capillary electrophoresis and laser-induced fluorescence detection. Clinical chemistry, 45(6 Pt 1), 862–868.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/10351996/"
target="right" >1999</a>)  </span>

have developed a
sensitive and robust method, based on capillary
electrophoresis and laser-induced fluorescence
detection, for quantifying the low physiological
concen&shy;trations of FMN and FAD, as well as
ribo&shy;flavin, in human plasma; later the method has
been developed further for assessment of ribo&shy;flavin
derivatives in erythrocytes

<span data-tippy-content="Hustad, S., McKinley, M. C., McNulty, H., Schneede, J., Strain, J. J., Scott, J. M., & Ueland, P. M. (2002). Riboflavin, flavin mononucleotide, and flavin adenine dinucleotide in human plasma and erythrocytes at baseline and after low-dose riboflavin supple&shy;mentation. Clinical chemistry, 48(9), 1571–1577.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/12194936/"
target="right" >Hustad et&nbsp;al., 2002</a>).  </span>

<h3 id="20b.2.4">20b.2.4	pyri&shy;dox&shy;amine phosphate oxidase (PPO)
activity and activity coefficient</h3>

The measurement of erythrocyte PPO enzyme activity
and its activity coefficient (PPO AC; assessed by the
ratio of PPO activity before and after <i>in vitro</i>
activation with the prosthetic group FMN) have been
suggested as alternatives to EGR&nbsp;AC for assessment
of ribo&shy;flavin status. This option could be very useful
for diagnosis of ribo&shy;flavin deficiency in populations
with a high prevalence of glucose-6-phosphate
dehy&shy;drogenase deficiency since the EGR&nbsp;AC assay
produces erroneous results in individuals with this
genetic defect

<span data-tippy-content="Thurnham D. I. (1972). Influence of glucose-6-phosphate dehy&shy;drogenase deficiency on the glutathione reductase test for ariboflavinosis. Annals of tropical medicine and parasitology, 66(4), 505–508.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/4656452/"
target="right" >Thurnham, 1972</a>;  </span>

<span data-tippy-content="Prentice, A. M., Bates, C. J., Prentice, A., Welch, S. G., Williams, K., & McGregor, I. A. (1981). The influence of G-6-PD activity on the response of erythrocyte glutathione reductase to riboflavin deficiency. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 51(3), 211–215.">
<a href="https://pubmed.ncbi.nlm.nih.gov/7319720/"
target="right" >Prentice et&nbsp;al., 1981</a>).  </span>


<p>
A&nbsp;fluorometric assay for measurement of PPO activity
in red blood cell lysates has been developed

<span data-tippy-content="Bates, C. J., & Powers, H. J. (1985). A simple fluorimetric assay for pyri&shy;dox&shy;amine phosphate oxidase in erythrocyte haemolysates: effects of riboflavin supple&shy;mentation and of glucose 6-phosphate dehy&shy;drogenase deficiency. Human nutrition. Clinical nutrition, 39(2), 107–115.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/4019261/"
target="right" >Bates and Powers, 1985</a>)  </span>


 and subsequently optimized and
adapted for assessment of PPO AC

<span data-tippy-content="Mushtaq, S., Su, H., Hill, M. H., & Powers, H. J. (2009). Erythrocyte pyri&shy;dox&shy;amine phosphate oxidase activity: a potential bio&shy;marker of riboflavin status?. The American journal of clinical nutrition, 90(5), 1151–1159.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/19740970/"
target="right" >Mushtaq et&nbsp;al., 2009</a>).  </span>


The results generated by this methodology
demonstrated that both PPO and PPO AC are
responsive to ribo&shy;flavin supple&shy;mentation and PPO
showed a strong dose-response effect. In addition, in
people free from glucose-6-phosphate dehy&shy;drogenase
deficiency, PPO and PPO AC strongly correlated with
the well-established bio&shy;marker of ribo&shy;flavin status,
EGR&nbsp;AC

<span data-tippy-content="Mushtaq, S., Su, H., Hill, M. H., & Powers, H. J. (2009). Erythrocyte pyri&shy;dox&shy;amine phosphate oxidase activity: a potential bio&shy;marker of riboflavin status?. The American journal of clinical nutrition, 90(5), 1151–1159.">
(<a href="https://pubmed.ncbi.nlm.nih.gov/19740970/"
target="right" >Mushtaq et&nbsp;al., 2009</a>).  </span>

Therefore, both PPO
and PPOAC are promising bio&shy;markers, however,
criteria to assess ribo&shy;flavin adequacy based on these
bio&shy;markers have not been developed yet.

<h3> Acknowledgements</h3>

KP would like to gratefully acknowledge the original contribution of Rosalind Gibson on which some parts of this chapter are based  and to express gratitude to Mike Jory and Ian Gibson for the HTML design and work in the translation to this HTML version. The assistance of Nutritional International for work on this chapter is also gratefully acknowledged.

</div>
   <script src="https://unpkg.com/@popperjs/core@2"></script>
<script src="https://unpkg.com/tippy.js@6"></script>
<script> tippy('[data-tippy-content]', { theme: 'nutass', interactive: true });
</script>


</body>




